Processing 00000000.tx.1: Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimers disease and variable expression Jessie Theuns, Jurgen Del-Favero, Bart Dermaut, Cornelia M. van Duijn1, Hubert Backhovens, Marleen Van den Broeck, Sally Serneels, Ellen Corsmit, Christine Van Broeckhoven and Marc Cruts+ Flanders Interuniversity Institute for Biotechnology (VIB), Born-Bunge Foundation (BBS), University of Antwerp (UIA), Department of Biochemistry, Antwerpen, Belgium and 1Department of Epidemiology and Biostatistics, Erasmus University Medical School, 3000 DR Rotterdam, The Netherlands Received 10 September 1999; 

Phrase: "Genetic variability in the regulatory region of presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2827666:Variability [Conceptual Entity]

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "variable expression Jessie Theuns,"

Phrase: "Jurgen Del-Favero,"

Phrase: "Bart Dermaut,"

Phrase: "Cornelia M. van Duijn1,"

Phrase: "Hubert Backhovens,"

Phrase: "Marleen Van den Broeck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0178587:DEN [Quantitative Concept]
   812   C0557775:Van [Manufactured Object]

Phrase: "Sally Serneels,"

Phrase: "Ellen Corsmit,"

Phrase: "Christine Van Broeckhoven"

Phrase: "and"

Phrase: "Marc Cruts+ Flanders Interuniversity Institute for Biotechnology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "(VIB"

Phrase: ")"

Phrase: ","

Phrase: "Born-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004897:Bear [Mammal]

Phrase: "Bunge Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "(BBS"

Phrase: ")"

Phrase: ","

Phrase: "University of Antwerp (UIA),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Antwerpen,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "and"

Phrase: "1Department of Epidemiology"

Phrase: "and"

Phrase: "Biostatistics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005544:biostatistics [Research Activity]
  1000   C2717898:Biostatistics [Research Activity]
  1000   C2718322:Biostatistics [Occupation or Discipline]

Phrase: "Erasmus University Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   812   C0036375:School [Manufactured Object,Organization]

Phrase: "3000 DR Rotterdam,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "10 September 1999"

Phrase: ";"
Processing 00000000.tx.2: Revised and Accepted 30 November 1999.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "30 November 1999."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Mutations in the presenilin 1 (PSEN1) gene have been implicated in 1850% of autosomal dominant cases with early-onset Alzheimers disease (EOAD). 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutations in the presenilin 1 (PSEN1) gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in 1850% of autosomal dominant cases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0443147:Autosomal dominant [Intellectual Product]
   748   C0596142:autosomal [Cell Component]
   748   C0868928:Cases [Functional Concept]
   748   C1527180:Dominant [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "with early-onset Alzheimers disease (EOAD)."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.4: Also, PSEN1 has been suggested as a potential risk gene in late-onset AD cases. 

Phrase: "Also,"

Phrase: "PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "been"

Phrase: "suggested as a potential risk gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017337:Gene [Gene or Genome]
   753   C0035647:Risk [Qualitative Concept]
   753   C3245505:Potential [Qualitative Concept]
   719   C1705535:Suggest [Idea or Concept]

Phrase: "in late-onset AD cases."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.5: We recently showed genetic association in a population-based study of EOAD, pointing to the 5' regulatory region of PSEN1. 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "genetic association in a population-based study"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C2717878:Study, Genetic Association [Molecular Biology Research Technique]
   778   C1328885:genetic association [Occupation or Discipline]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "of EOAD,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "pointing to the 5' regulatory region of PSEN1."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C0220905:regulatory [Regulation or Law]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1704735:Regulatory [Conceptual Entity]
   708   C1552961:Point [Quantitative Concept]
   708   C2347617:point [Quantitative Concept]
Processing 00000000.tx.6: In this study we systematically screened 3.5 kb of the PSEN1 upstream region and found four novel polymorphisms. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we systematically"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "3.5 kb of the PSEN1 upstream region"

Phrase: "and"

Phrase: "found four novel polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.7: Genetic analysis confirmed association of two polymorphisms with increased risk for EOAD. 

Phrase: "Genetic analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0679560:genetic analysis [Laboratory Procedure]
  1000   C0796344:Genetic Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "association of two polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   861   C0035647:Risk [Qualitative Concept]
   861   C0205217:Increased [Quantitative Concept]
   861   C0442805:Increased [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "for EOAD."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.8: In addition, we detected two different mutations in EOAD cases at 280 and 2818 relative to the transcription initiation site in exon 1A of PSEN1. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "two different mutations in EOAD cases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "at 280"

Phrase: "and"

Phrase: "2818 relative to the transcription initiation site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "in exon 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "of PSEN1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.9: Analysis of the mutant and wild-type 280 variants using luciferase reporter gene expression in transiently transfected neuroblastoma cells showed a 30% decrease in transcriptional activity for the mutant 280G PSEN1 promoter variant compared with the wild-type variant 280C. 

Phrase: "Analysis of the mutant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "wild-type 280 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "luciferase reporter gene expression in transiently transfected neuroblastoma cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0017262:Gene Expression [Genetic Function]
   764   C0206414:Reporter Gene [Gene or Genome]
   762   C1334435:Luciferase Gene [Gene or Genome]
   745   C1861886:CELL Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 30% decrease in transcriptional activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "for the mutant 280G PSEN1 promoter variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205419:Variant [Qualitative Concept]

Phrase: "compared with the wild-type variant 280C."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0205419:Variant [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]
   748   C1707455:Compared [Activity]
Processing 00000000.tx.10: Our data suggest that the increased risk for EOAD associated with PSEN1 may result from genetic variations in the regulatory region leading to altered expression levels of the PSEN1 protein.  

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the increased risk for EOAD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1281905:disease risk [Finding]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   721   C0277564:Acquired disease [Disease or Syndrome]

Phrase: "associated with PSEN1"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "may"

Phrase: "result from genetic variations"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   833   C0042333:Variations, Genetic [Natural Phenomenon or Process]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0205419:variations [Qualitative Concept]
   770   C0314603:Genetic [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "in the regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "leading to altered expression levels of the PSEN1 protein."
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   757   C1171362:expression protein [Genetic Function]
   741   C0428255:lead levels [Laboratory or Test Result]
   741   C0428479:Protein level [Laboratory or Test Result]
   741   C0456947:Level 1 [Intellectual Product]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0332152:Leading [Temporal Concept]
   739   C0392747:Altered [Functional Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   739   C1522538:Leading [Functional Concept]
   726   C3244092:expression level [Idea or Concept]
   724 E C0524167:Lead level [Laboratory Procedure]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C0456079:Level [Classification]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1547707:Level [Geographic Area]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C2946261:Level [Pharmacologic Substance]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Alzheimers disease (AD) is the most common form of senile dementia and the fourth leading cause of death in western societies. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimers disease (AD)"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "the most common form of senile dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "the fourth leading cause of death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007465:Cause of Death [Finding]
           Death Cause
   833   C0804771:Cause of death [Clinical Attribute]
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in western societies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0680323:Western society [Population Group]
   861   C0037455:Societies [Organization]
Processing 00000000.tx.12: Although AD occurs most frequently in the elderly population [late-onset or senile AD (LOAD)], in 12% of the cases the first symptoms become apparent before the age of 65 years [early-onset or presenile AD (EOAD)] (1). 

Phrase: "Although"

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "most frequently in the elderly population"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001792:Elderly [Population Group]
   753   C0032659:Population [Quantitative Concept]
   753   C0205393:Most [Quantitative Concept]
   753   C0332183:Frequently [Temporal Concept]
   753   C1257890:Population [Population Group]
   753   C1999167:elderly [Population Group]

Phrase: "[late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "or"

Phrase: "senile AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(LOAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: ")"

Phrase: "],"

Phrase: "in 12%"

Phrase: "of the cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the first symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "become"

Phrase: "apparent before the age of 65 years"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0521994:Apparent age [Organism Attribute]
   748   C0750489:apparent [Idea or Concept]

Phrase: "[early-onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1833334:Early-onset [Finding]
   861   C0332162:Onset [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "or"

Phrase: "presenile AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(EOAD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "]"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: In 4060% of AD cases a positive family history for dementia has been documented (2). 

Phrase: "In 4060%"

Phrase: "of AD cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "a positive family history for dementia"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0241889:Family history [Finding]
   790   C1705495:Family History [Idea or Concept]
   753   C0015576:Family [Family Group]
   753   C0019664:History [Occupation or Discipline]
   753   C0019665:history [Intellectual Product]
   753   C0262512:History, NOS [Organism Attribute]
   753   C0262926:History [Finding]
   753   C1704727:Family [Conceptual Entity]
   753   C1705255:History [Conceptual Entity]
   753   C2004062:History [Finding]
   748   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]

Phrase: "has"

Phrase: "been"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: In 10% of familial cases, AD is inherited as an autosomal dominant trait. 

Phrase: "In 10%"

Phrase: "of familial cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "inherited as an autosomal dominant trait."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178491:autosomal dominant trait [Organism Attribute]
   790   C0443147:Autosomal dominant [Intellectual Product]
   753   C0439660:Inherited [Functional Concept]
   753   C0596142:autosomal [Cell Component]
   753   C0599883:Trait [Organism Attribute]
   753   C1527180:Dominant [Functional Concept]
Processing 00000000.tx.15: Eighteen to fifty per cent of familial autosomal dominant EOAD cases can be explained by mutations in the presenilin 1 gene (PSEN1) (35). 

Phrase: "Eighteen to fifty per cent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0439165:Percent [Quantitative Concept]
   760   C0562018:cent [Quantitative Concept]

Phrase: "of familial autosomal dominant EOAD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   793   C0868928:Cases [Functional Concept]
   793   C1533148:Cases [Quantitative Concept]
   760 E C1706255:CASE [Medical Device]
   760 E C1706256:Case [Conceptual Entity]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   711   C0277558:Familial disease [Disease or Syndrome]

Phrase: "can"

Phrase: "be"

Phrase: "explained by mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the presenilin 1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.16: Other genes that are mutated in autosomal dominant EOAD cases are the amyloid precursor protein (APP) and presenilin 2 (PSEN2) genes (6,7). 

Phrase: "Other genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "are"

Phrase: "mutated in autosomal dominant EOAD cases"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   818   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   781   C0814120:early disease onset [Disease or Syndrome]
   764   C0002395:Alzheimers disease [Disease or Syndrome]
   764   C0443147:Autosomal dominant [Intellectual Product]
   764   C1833334:Early-onset [Finding]
   762   C0277793:disease onset [Temporal Concept]
   762   C0679245:early disease [Temporal Concept]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0332162:Onset [Qualitative Concept]
   742   C0596142:autosomal [Cell Component]
   742   C0868928:Cases [Functional Concept]
   742   C1279919:Early [Temporal Concept]
   742   C1527180:Dominant [Functional Concept]
   742   C1533148:Cases [Quantitative Concept]
   742   C1705285:Mutated [Cell or Molecular Dysfunction]
   708 E C1513776:Mutate [Genetic Function]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "the amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "presenilin 2 (PSEN2) genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Genes [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.17: Also, the E4 allele of the apolipoprotein E gene (APOE4) was shown to increase risk for developing LOAD and EOAD (8,9). 

Phrase: "Also,"

Phrase: "the E4 allele of the apolipoprotein E gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C3642141:Apolipoprotein E4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "(APOE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "risk for developing LOAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "EOAD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.18: No PSEN1 mutations were found in LOAD patients; 

Phrase: "No PSEN1 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "were"

Phrase: "found in LOAD patients"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   802   C1709487:Patient Load [Quantitative Concept]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0150312:Found [Quantitative Concept]
   770   C1550025:Load [Idea or Concept]
   770   C1704782:Load [Manufactured Object]
   770   C1708715:Load [Activity]
   737 E C0243095:Find [Finding]

Phrase: ";"
Processing 00000000.tx.19: however, a genetic association was reported between a di-allelic polymorphism in intron 8 of PSEN1 and LOAD (10). 

Phrase: "however,"

Phrase: "a genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "reported between a di-allelic polymorphism"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0032529:Polymorphism [Genetic Function]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1882417:Polymorphism [Qualitative Concept]
   753   C3496591:Reported [Clinical Attribute]
   753   C3538902:DI [Gene or Genome]
   753   C3541881:DI [Idea or Concept]
   719 E C3273238:Report [Intellectual Product]

Phrase: "in intron 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "LOAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.20: Association was present in a Caucasian North-American but not in an African-American population, suggesting that the intron 8 polymorphism may be in linkage disequilibrium with functionally more relevant sequence variations elsewhere in the PSEN1 gene (10). 

Phrase: "Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "present in a Caucasian North-American"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "not in an African-American population,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0085756:African American [Population Group]
   753   C0027567:African [Population Group]
   753   C0032659:Population [Quantitative Concept]
   753   C0596070:American [Population Group]
   753   C1257890:Population [Population Group]
   753   C1518422:Not [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the intron 8 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "be in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C2987476:Be [Conceptual Entity]

Phrase: "with functionally more relevant sequence variations elsewhere"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C0205419:variations [Qualitative Concept]
   799   C1519249:Sequence [Functional Concept]
   793   C0042333:Sequence Variation [Natural Phenomenon or Process]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "in the PSEN1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.21: However, sequence analysis failed to detect sequence variations in the coding region. 

Phrase: "However,"

Phrase: "sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "sequence variations in the coding region."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0079941:Coding Sequence [Gene or Genome]
   756   C0042333:Sequence Variation [Natural Phenomenon or Process]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0205419:variations [Qualitative Concept]
   753   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.22: We recently analysed several polymorphisms within and near the PSEN1 gene for genetic association with EOAD in a population-based casecontrol sample (11). 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "analysed"

Phrase: "several polymorphisms within"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0032529:polymorphisms [Genetic Function]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and near the PSEN1 gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017337:Gene [Gene or Genome]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   753   C1515981:And [Idea or Concept]

Phrase: "for genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "with EOAD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "in a population-based casecontrol sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0370003:Sample [Substance]
   812   C2347026:Sample [Conceptual Entity]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.23: We found significant association with the intron 8 polymorphism (P = 0.05) as well as with a promoter polymorphism located 48 bp upstream of the transcription initiation site of PSEN1 (48CT; P = 0.03) (3,11) and a simple tandem repeat (STR) polymorphism D14S1028 located upstream of PSEN1 (11). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "significant association with the intron 8 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "(P = 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "as well as with a promoter polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032529:Polymorphism [Genetic Function]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205170:Well [Qualitative Concept]
   748   C1882417:Polymorphism [Qualitative Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "located"

Phrase: "48 bp upstream of the transcription initiation site of PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   754   C2984182:BP-1 [Gene or Genome]

Phrase: "(48CT"

Phrase: "; P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "11"

Phrase: ")"

Phrase: "and"

Phrase: "a simple tandem repeat (STR) polymorphism D14S1028"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1519303:Simple Tandem Repeat Polymorphism [Nucleotide Sequence]

Phrase: "located upstream of PSEN1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0522505:Upstream [Spatial Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.24: However, the intron 8 association was fully explained by linkage disequilibrium with the dominant PSEN1 mutations. 

Phrase: "However,"

Phrase: "the intron 8 association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "fully"

Phrase: "explained by linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with the dominant PSEN1 mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.25: The association with the polymorphisms in the regulatory region remained after excluding PSEN1 mutation carriers from the analysis. 

Phrase: "The association with the polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in the regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "remained after excluding PSEN1 mutation carriers"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   762   C2985478:Mutation Carrier [Human]
   748   C0007294:carriers [Finding]
   748   C0026882:Mutation [Genetic Function]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   714   C0332196:Exclude [Functional Concept]
   714 E C0560175:Carrier [Finding]
   714 E C1706209:Carrier [Medical Device]
   714   C2828389:Exclude [Activity]
   714 E C3273162:Carrier [Intellectual Product]

Phrase: "from the analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]
Processing 00000000.tx.26: Of the promoter polymorphism 48CT (3), the most frequent allele C was associated with an increased risk for EOAD [odds ratio (OR) = 2.6] due to over-representation of the CC genotype in the cases, independent of the APOE4 allele (11). 

Phrase: "Of the promoter polymorphism 48CT"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "the most frequent allele C"

Phrase: "was"

Phrase: "associated with an increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for EOAD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "[odds ratio (OR)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 2.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "]"

Phrase: "due to over-representation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205136:Over [Spatial Concept]
   861   C1514861:Representation [Conceptual Entity]
   861   C1882932:Representation [Activity]

Phrase: "of the CC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "in the cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "independent of the APOE4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Allele [Gene or Genome]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.27: These data suggested that genetic variants within the PSEN1 regulatory region might be implicated in AD pathogenesis. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that genetic variants within the PSEN1 regulatory region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:variants [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "implicated in AD pathogenesis."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0002395:Alzheimers disease [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.28: The PSEN1 gene consists of 13 exons, three non-coding exons (exons 1A, 1B and 2) and 10 coding exons (exons 312) (12). 

Phrase: "The PSEN1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "consists of 13 exons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0332529:CONSIST [Qualitative Concept]

Phrase: "three non-coding exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(exons 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "10 coding exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(exons 312"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.29: PSEN1 is ubiquitously expressed; 

Phrase: "PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "ubiquitously"

Phrase: "expressed"

Phrase: ";"
Processing 00000000.tx.30: however, exons 1A and 1B are alternatively used with the exon 1B transcript found only once in a colon adenocarcinoma cDNA library (13). 

Phrase: "however,"

Phrase: "exons 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "are"

Phrase: "alternatively"

Phrase: "used with the exon 1B transcript"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0450345:1B [Intellectual Product]
   753   C1273517:used [Finding]
   753   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "once in a colon adenocarcinoma cDNA library"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0338106:Colon Adenocarcinoma [Neoplastic Process]
   778   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   748   C0001418:Adenocarcinoma [Neoplastic Process]
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0009368:Colon [Body Part, Organ, or Organ Component]
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1281569:Colon [Body Part, Organ, or Organ Component]
   748   C1720092:Once [Intellectual Product]
   748   C1948045:Once [Temporal Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: We determined the genomic organization of PSEN1 by fibre-FISH analysis and restriction mapping of a clone contig spanning PSEN1 (14). 

Phrase: "We"

Phrase: "determined"

Phrase: "the genomic organization of PSEN1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0029237:Organisation [Physiologic Function]
   753   C0029246:Organization [Organization]
   753   C0220885:organization [Qualitative Concept]
   753   C1300196:Organization [Functional Concept]
   753   C1522486:Organization [Professional or Occupational Group]

Phrase: "by fibre-FISH analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1517169:Fiber FISH [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "restriction mapping of a clone contig spanning PSEN1"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   764   C0035269:Restriction Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   762   C0600629:Contig Mapping [Molecular Biology Research Technique]
   745   C1424473:MAP-1 [Gene or Genome]
   742   C0443288:Restriction [Functional Concept]
   742   C1283195:Mapping [Activity]
   708 E C0024779:Map [Manufactured Object]
   708 E C1706473:Map [Conceptual Entity]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.32: In addition to the coding region the clone contig contains ~28 kb of sequences upstream of exon 1B. 

Phrase: "In addition to the coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "the clone contig"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511491:Contig [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "~28 kb of sequences"

Phrase: "upstream of exon 1B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]
Processing 00000000.tx.33: In this study we sequenced 6.7 kb of upstream sequences and systematically analysed 3.5 kb for genetic variations associated with EOAD.  

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "6.7 kb of upstream sequences"

Phrase: "and"

Phrase: "systematically"

Phrase: "analysed"

Phrase: "3.5 kb for genetic variations"

Phrase: "associated with EOAD."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1833334:Early-onset [Finding]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.34: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  PSEN1 promoter polymorphisms We subcloned four restriction fragments of plasmid B22 (14), representing a 6.7 kb sequence upstream of exon 1B in the pOCUS-2 vector for transposon-based genomic sequencing: the 3.2 kb EcoRIPstI, 2.1 kb PstI, 2.5 kb PstI and 2.2 kb HindIIIEcoRI fragments (Fig. 1A). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "PSEN1 promoter polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "We subcloned four restriction fragments of plasmid B22"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0332255:fragments [Functional Concept]
   744   C0443288:Restriction [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "a 6.7 kb"

Phrase: "sequence upstream of exon 1B"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0450345:1B [Intellectual Product]
   760   C0522505:Upstream [Spatial Concept]
   760   C1519249:Sequence [Functional Concept]

Phrase: "in the pOCUS-2 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "for transposon-based genomic sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1553778:Sequencing [Intellectual Product]
   812   C1561491:Sequencing [Functional Concept]

Phrase: ":"

Phrase: "the 3.2 kb EcoRIPstI,"

Phrase: "2.1 kb PstI,"

Phrase: "2.5 kb PstI"

Phrase: "and"

Phrase: "2.2 kb HindIIIEcoRI fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.35: In total, 9642 bp were sequenced (GenBank accession no. AF205592), of which 6698 bp were upstream of exon 1B. 

Phrase: "In total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "9642 bp"

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "(GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. AF205592"

Phrase: ")"

Phrase: ","

Phrase: "of which 6698 bp"

Phrase: "were upstream of exon 1B."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0450345:1B [Intellectual Product]
   760   C0522505:Upstream [Spatial Concept]
Processing 00000000.tx.36: View larger version (15K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.37: Sequence variations in the 5' upstream region of PSEN1. 

Phrase: "Sequence variations in the 5' upstream region of PSEN1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0205419:variations [Qualitative Concept]
   739   C1519249:Sequence [Functional Concept]
   726   C0042333:Sequence Variation [Natural Phenomenon or Process]
Processing 00000000.tx.38: Positions are numbered relative to the transcription start site of exon 1A (13). 

Phrase: "Positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:positions [Spatial Concept]
   916 E C0240795:POSITIONAL [Finding]

Phrase: "are"

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "relative to the transcription start site of exon 1A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.39: Open bars represent exons. 

Phrase: "Open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "exons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.40: (A) Plasmid B22 showing the restriction sites used for the subcloning: E, EcoRI; 

Phrase: "(A) Plasmid B22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417641:B22 [Gene or Genome]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   966   C1882940:Restriction Site [Nucleotide Sequence]
   861   C0205145:Sites [Spatial Concept]
   861   C0443288:Restriction [Functional Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "used for the subcloning"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "E,"

Phrase: "EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.41: P, PstI; 

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "PstI"

Phrase: ";"
Processing 00000000.tx.42: H, HindIII. 

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "HindIII."
Processing 00000000.tx.43: (B) Region of B22 subjected to systematic polymorphism/mutation analyses. 

Phrase: "(B) Region of B22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "subjected to systematic polymorphism/mutation analyses."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   773   C0796357:mutation analysis [Laboratory Procedure]
   767   C0796451:polymorphism analysis [Diagnostic Procedure]
   753   C0026882:Mutation [Genetic Function]
   753   C0032529:Polymorphism [Genetic Function]
   753   C0220922:systematic [Functional Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C1882417:Polymorphism [Qualitative Concept]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0681850:Subject [Group]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
Processing 00000000.tx.44: Sequence variations are represented by upper case (allele present in plasmid B22/alternative allele). 

Phrase: "Sequence variations"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   966   C0042333:Sequence Variation [Natural Phenomenon or Process]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0205419:variations [Qualitative Concept]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "represented by upper case"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0868928:Case [Functional Concept]
   770   C1282910:Upper [Spatial Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]
   737   C1882932:Represent [Activity]

Phrase: "(allele present in plasmid B22/alternative allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.45: The sequences of potential cis elements detected by MatInspector V 2.2 (35) are within rectangles. 

Phrase: "The sequences of potential cis elements"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "detected by MatInspector V 2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0445362:V 2 [Intellectual Product]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(35"

Phrase: ")"

Phrase: "are within rectangles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1551058:Are [Quantitative Concept]
   756   C0205142:Rectangle [Spatial Concept]
Processing 00000000.tx.46: In the case of allele-specific presence of the binding site the particular allele is indicated in brackets.  

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of allele-specific presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0392148:Presence [Therapeutic or Preventive Procedure]
   755 E C0150312:Present [Quantitative Concept]
   755 E C0449450:Present [Idea or Concept]

Phrase: "of the binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005456:Binding Site [Receptor]
  1000   C0682969:Binding Site [Amino Acid Sequence]
   861   C0205145:Site [Spatial Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "the particular allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "indicated in brackets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0179407:brackets [Medical Device]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.47: We systematically screened 3.5 kb upstream of exon 1B (Fig. 1B) in 10 randomly selected control individuals by polymerase chain reactionsingle-strand conformation polymorphism (PCRSSCP) analysis using 16 overlapping primer sets. 

Phrase: "We systematically"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "3.5 kb upstream of exon 1B"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "in 10 randomly selected control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0027361:Individual [Population Group]
   771   C0237401:Individual [Human]

Phrase: "by polymerase chain reactionsingle-strand conformation polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(PCRSSCP) analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "16 overlapping primer sets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.48: Four PCR fragments gave altered SSCP patterns and cycle sequencing revealed five polymorphisms (Table 1). 

Phrase: "Four PCR fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "altered SSCP patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "cycle sequencing revealed five polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0032529:polymorphisms [Genetic Function]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.49: One is 48CT that we reported previously (3) (Table 1), abolishing an HgaI site allowing for its detection by PCRrestriction fragment lengthpolymorphism (RFLP) analysis (Fig. 2). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "48CT"

Phrase: "that"

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "abolishing"

Phrase: "an HgaI site allowing for its detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0683607:allowing [Social Behavior]

Phrase: "by PCRrestriction fragment lengthpolymorphism"

Phrase: "(RFLP) analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0200930:RFLP analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0035268:RFLP [Clinical Attribute]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.50: The other four are novel polymorphisms: two single nucleotide changes at positions 1789 (1789GA) and 2154 (2154GA); 

Phrase: "The"

Phrase: "other four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "are"

Phrase: "novel polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "two single nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "changes at positions 1789"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0444793:change positions [Health Care Activity]
   802 E C0580859:Changes position [Finding]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0733755:positions [Spatial Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "(1789GA"

Phrase: ")"

Phrase: "and"

Phrase: "2154"

Phrase: "(2154GA"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.51: and two complex variations, i.e. a T-stretch at 2319 (2319Tn) and a 13 bp insertion/deletion at 2823 (2823I/D) (Table 1). 

Phrase: "and"

Phrase: "two complex variations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variations [Qualitative Concept]

Phrase: "i.e. a T-stretch at 2319"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "(2319Tn"

Phrase: ")"

Phrase: "and"

Phrase: "a 13 bp insertion/deletion at 2823"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "(2823I/"

Phrase: "D) ("

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.52: 2154GA and 2823I/D involve restriction enzyme recognition sites forBsmBI and NlaIII, respectively, and can be detected by aPCRRFLP assay (Fig. 2). 

Phrase: "2154GA"

Phrase: "and"

Phrase: "2823I/D"

Phrase: "involve"

Phrase: "restriction enzyme recognition sites forBsmBI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1882940:Restriction Enzyme Recognition Site [Nucleotide Sequence]
           Restriction Enzyme Site

Phrase: "and"

Phrase: "NlaIII,"

Phrase: "respectively,"

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "detected by aPCRRFLP assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.53: For 1789GA we developed anHgaI mismatch PCRRFLP assay (Fig. 2). 

Phrase: "For 1789GA"

Phrase: "we"

Phrase: "developed"

Phrase: "anHgaI mismatch PCRRFLP assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.54: SSCP analysis of 2319Tn was complex, also because the T-stretch is contained in the same PCR fragment comprising the 2154GA polymorphism. 

Phrase: "SSCP analysis of 2319Tn"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1519159:SSCP Analysis [Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "complex, also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "because"

Phrase: "the T-stretch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "contained in the same PCR fragment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0332255:fragment [Functional Concept]
   753   C0332256:contained [Functional Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C0677874:pCR [Finding]
   753   C1708096:Fragment [Qualitative Concept]
   753   C2700400:Contained [Activity]

Phrase: "comprising"

Phrase: "the 2154GA polymorphism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.55: Sequencing indicated that the T-stretch is highly polymorphic although the number of T alleles could not be determined exactly. 

Phrase: "Sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the T-stretch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "highly polymorphic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1882417:Polymorphic [Qualitative Concept]
   789 E C0027950:Polymorph [Cell]

Phrase: "although"

Phrase: "the number of T alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "exactly."
Processing 00000000.tx.56: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.57: Sequence variations detected in the PSEN1 5' upstream region  View larger version (49K): [in this window] [in a new window]  Figure 2. 

Phrase: "Sequence variations"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   966   C0042333:Sequence Variation [Natural Phenomenon or Process]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0205419:variations [Qualitative Concept]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "detected in the PSEN1 5' upstream region"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C1883644:Upstream Region [Nucleotide Sequence]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0442726:Detected [Finding]
   744   C0522505:Upstream [Spatial Concept]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.58: PCRRFLP analysis of sequence variations in the PSEN1 regulatory region (Table 1).  

Phrase: "PCRRFLP analysis of sequence variations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in the PSEN1 regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.59: Genetic association We analysed the EOAD casecontrol sample for genetic association with the three novel polymorphisms: 1789GA, 2154GA and 2823I/D. 

Phrase: "Genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "We"

Phrase: "analysed"

Phrase: "the EOAD casecontrol sample for genetic association"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0444241:Genetic sample [Cell Component]
   739   C0370003:Sample [Substance]
   739   C2347026:Sample [Conceptual Entity]
   716 E C0586526:Genital sample [Body Part, Organ, or Organ Component]

Phrase: "with the three novel polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "1789GA,"

Phrase: "2154GA"

Phrase: "and"

Phrase: "2823I/D."
Processing 00000000.tx.60: In the same EOAD casecontrol sample we have previously analysed 48CT and found positive association with the C-allele and an over-representation of the CC genotype in cases versus controls (Table 2) (11). 

Phrase: "In the same EOAD casecontrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "we"

Phrase: "have"

Phrase: "previously analysed 48CT"

Phrase: "and"

Phrase: "found positive association with the C-allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "an over-representation of the CC genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "versus"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.61: For all three polymorphisms, genotype frequencies were in HardyWeinberg equilibrium in the control population (Table 2). 

Phrase: "For all three polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "genotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "were in HardyWeinberg equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014653:Equilibrium [Organism Function]
   770   C1547026:Equilibrium [Quantitative Concept]

Phrase: "in the control population"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.62: Also, 2154GA and 2823I/D were in nearly complete linkage disequilibrium with 48CT (P < 6.1015): the risk allele C of 48CT is linked to the G allele of 2154GA andthedeletion allele of 2823I/D resulting in similar ORs forthesepolymorphisms (Table 2). 

Phrase: "Also,"

Phrase: "2154GA"

Phrase: "and"

Phrase: "2823I/D"

Phrase: "were in nearly"

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "linkage disequilibrium with 48CT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "(P < 6.1015"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ":"

Phrase: "the risk allele C of 48CT"

Phrase: "is"

Phrase: "linked to the G allele of 2154GA andthedeletion allele of 2823I/D"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0439417:g d [Quantitative Concept]
   736   C0002085:Allele [Gene or Genome]
   736   C0439267:g% [Quantitative Concept]
   703   C1517892:Link [Intellectual Product]
   703   C1704666:Link [Intellectual Product]

Phrase: "resulting in similar ORs forthesepolymorphisms"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0332294:Resulting in [Functional Concept]
   760   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]
   760   C0678226:resulting [Functional Concept]
   760   C2348205:Similar [Qualitative Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.63: No association was detected with 1789GA (Table 2). 

Phrase: "No association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "detected with 1789GA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.64: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.65: Genetic association of polymorphisms in the PSEN1 5' regulatory region in EOAD cases and controls  PSEN1 promoter mutations When analysing 2823I/D by PCRSSCP in the EOAD casecontrol sample, an additional variation was observed in one EOAD patient. 

Phrase: "Genetic association of polymorphisms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1328885:genetic association [Occupation or Discipline]
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "in the PSEN1 5' regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   804   C0220905:regulatory [Regulation or Law]
   804   C1704735:Regulatory [Conceptual Entity]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]

Phrase: "in EOAD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]
   708   C0679245:early disease [Temporal Concept]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "PSEN1 promoter mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "When"

Phrase: "analysing 2823I/D by PCRSSCP"

Phrase: "in the EOAD casecontrol sample,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0370003:Sample [Substance]
   799   C2347026:Sample [Conceptual Entity]
   734   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]

Phrase: "an additional variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "was"

Phrase: "observed in one EOAD patient."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   789   C0814120:early disease onset [Disease or Syndrome]
   770   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C1833334:Early-onset [Finding]
   767   C0277793:disease onset [Temporal Concept]
   767   C0679245:early disease [Temporal Concept]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0030705:*^patient [Patient or Disabled Group]
   744   C0205447:One [Quantitative Concept]
   744   C0332162:Onset [Qualitative Concept]
   744   C1279919:Early [Temporal Concept]
   744   C1441672:Observed [Functional Concept]
Processing 00000000.tx.66: Sequence analysis demonstrated a heterozygous AG transition at position 2818 (2818AG) creating a BanI site (Table 1; Fig. 2). 

Phrase: "Sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "a heterozygous AG transition at position 2818"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0599156:Transition [Cell or Molecular Dysfunction]
   748   C2700061:Transition [Activity]

Phrase: "(2818AG"

Phrase: ")"

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "a BanI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "; Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.67: PCRRFLP analysis of the EOAD casecontrol sample confirmed the presence of 2818AG in the one patient, whereas all other patients and controls were homozygous for the A allele. 

Phrase: "PCRRFLP analysis of the EOAD casecontrol sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1303103:Sample analysis [Laboratory Procedure]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of 2818AG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the one patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "whereas"

Phrase: "all other patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "homozygous for the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0019904:Homozygous [Organism Attribute]

Phrase: "A allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.68: In addition, we systematically analysed the 372 to 33 promoter fragment by PCRSSCP analysis for mutations in the EOAD cases. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we systematically"

Phrase: "analysed"

Phrase: "the 372 to 33 promoter fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "by PCRSSCP analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "for mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the EOAD cases."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]
   708   C0679245:early disease [Temporal Concept]
Processing 00000000.tx.69: In our previous study we had already analysed the 134 to +163 fragment revealing 48CT but no mutations (3). 

Phrase: "In our previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "had"

Phrase: "already"

Phrase: "analysed"

Phrase: "the 134 to +163 fragment revealing 48CT"

Phrase: "but"

Phrase: "no mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.70: In one patient, we detected a heterozygous CG transversion at position 280 (280CG), creating an NcoI site (Table 1; Fig.2). 

Phrase: "In one patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a heterozygous CG transversion at position 280"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0599157:Transversion [Cell or Molecular Dysfunction]

Phrase: "(280CG"

Phrase: ")"

Phrase: ","

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "an NcoI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "; Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.71: Again, PCRRFLP analysis confirmed the presence of the mutation in the one patient with all other patients and controls being homozygous for the C allele. 

Phrase: "Again,"

Phrase: "PCRRFLP analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of the mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the one patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with all"

Phrase: "other patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "being"

Phrase: "homozygous for the C allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]
Processing 00000000.tx.72: Reporter gene analysis We cloned the 1554 bp KpnIHindIII fragment of B22 corresponding to the 318 to +1226 region (14) into the luciferase reporter vector pGL3-basic. 

Phrase: "Reporter gene analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0206414:Reporter Gene [Gene or Genome]

Phrase: "We"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the 1554 bp KpnIHindIII fragment of B22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to the 318 to +1226 region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "into the luciferase reporter vector pGL3-basic."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1527178:Basic [Functional Concept]
   733 E C0920750:basicity [Quantitative Concept]
Processing 00000000.tx.73: The G allele of 280CG was introduced in the construct by in vitro mutagenesis and sequence integrity was confirmed by sequencing. 

Phrase: "The G allele of 280CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "introduced in the construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2827421:Construct [Classification]
   737   C1292748:introduce [Functional Concept]

Phrase: "by in vitro mutagenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0079866:Mutagenesis [Molecular Function]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "sequence integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.74: The effect of the wild-type (280C) and mutant (280G) alleles on the transcriptional activity of the PSEN1 promoter was studied in transiently transfected cells. 

Phrase: "The effect of the wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(280C"

Phrase: ")"

Phrase: "and"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(280G"

Phrase: ")"

Phrase: "alleles on the transcriptional activity of the PSEN1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0002085:Alleles [Gene or Genome]

Phrase: "was"

Phrase: "studied in transiently transfected cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726   C0557651:Study [Manufactured Object]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726   C2603343:Study [Research Activity]
Processing 00000000.tx.75: In human embryonic kidney (HEK293) cells no significant differences in expression levels were detected between 280G and 280C (Fig. 3). 

Phrase: "In human embryonic kidney"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0086418:Human [Human]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(HEK293"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "no significant differences in expression levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "detected between 280G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "280C"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.76: In mouse Neuro2A-neuroblastoma (N2A) cells, however, a 30% decrease was detected for 280G (Fig. 3). 

Phrase: "In mouse Neuro2A-neuroblastoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1524043:Mouse Neuroblastoma [Neoplastic Process]
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(N2A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "however,"

Phrase: "a 30% decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "detected for 280G"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.77: Notably, the promoter activity of 280C in N2A cells and HEK293 cells was comparable (data not shown). 

Phrase: "Notably,"

Phrase: "the promoter activity of 280C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "in N2A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "comparable"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.78: View larger version (11K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.79: Transcriptional activity of the PSEN1 280C/G variants in transient transfection experiments. 

Phrase: "Transcriptional activity of the PSEN1 280C/G variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "in transient transfection experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.80: Bars represent firefly/renilla luciferase ratios for the different constructs [relative luciferase activity (RLA)]. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "firefly/renilla luciferase ratios for the different constructs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0456603:Ratios [Quantitative Concept]
   744   C1610540:*Ratios [Quantitative Concept]
   711 E C1547037:Ratio [Intellectual Product]

Phrase: "[relative luciferase activity (RLA)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.81: Transcriptional activities are presented as a percentage of the activity of the wild-type construct (280C, white bars). 

Phrase: "Transcriptional activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "presented as a percentage of the activity of the wild-type construct"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   766   C0459205:Type of activity [Intellectual Product]
   753   C1883559:Wild Type [Organism Attribute]
   736   C0205177:Activity [Functional Concept]
   736   C0332307:Type [Qualitative Concept]
   736   C0439165:Percentage [Quantitative Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C0445392:Wild [Intellectual Product]
   736   C0449450:Presented [Idea or Concept]
   736   C1547052:*Type [Quantitative Concept]
   736   C1549488:Percentage [Idea or Concept]
   736   C1561533:Percentage [Idea or Concept]
   736   C1561536:*Activity [Idea or Concept]
   736   C2827421:Construct [Classification]
   703 E C0150312:Present [Quantitative Concept]

Phrase: "(280C,"

Phrase: "white bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: Values are the means  SEM of duplicate determinations of at least three experiments of three independent DNA preparations each.   

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the means  SEM of duplicate determinations of"

Phrase: "at least three experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "of three independent DNA preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "each."
Processing 00000000.tx.83: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Following our previous observation of genetic association of the PSEN1 48CT promoter polymorphism with increased risk for EOAD (11), we aimed in this study at analysing systematically the regulatory region of PSEN1 for genetic variations. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "our previous observation of genetic association of the PSEN1 48CT promoter polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   735   C0302523:Observation [Research Activity]
   735   C0700325:observation [Health Care Activity]
   735   C1964257:Observation [Diagnostic Procedure]
   707   C0577203:Genital observation [Finding]

Phrase: "with increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   861   C0035647:Risk [Qualitative Concept]
   861   C0205217:Increased [Quantitative Concept]
   861   C0442805:Increased [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "for EOAD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "aimed in this study"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C1947946:Aim [Idea or Concept]
   737   C2948600:Aim [Pharmacologic Substance]
   737   C3540471:AIM [Gene or Genome]
   737   C3540472:AIM [Functional Concept]

Phrase: "at analysing systematically"

Phrase: "the regulatory region of PSEN1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0220905:regulatory [Regulation or Law]
   753   C1704735:Regulatory [Conceptual Entity]

Phrase: "for genetic variations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042333:Variations, Genetic [Natural Phenomenon or Process]
   861   C0205419:variations [Qualitative Concept]
Processing 00000000.tx.84: Starting from a clone contig of PSEN1 that we had previously constructed (14), we determined 6.7 kb of genomic sequence upstream of PSEN1 exon 1B. 

Phrase: "Starting from a clone contig of PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0439659:Start [Temporal Concept]

Phrase: "that"

Phrase: "we"

Phrase: "had"

Phrase: "previously"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "determined"

Phrase: "6.7 kb of genomic sequence"

Phrase: "upstream of PSEN1 exon 1B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450345:1B [Intellectual Product]
Processing 00000000.tx.85: No TATA box or initiator sequences were found within the 200 bp upstream promoter region. 

Phrase: "No TATA box"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080206:TATA Box [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "or"

Phrase: "initiator sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "found within the 200 bp upstream promoter region."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767   C1883644:Upstream Region [Nucleotide Sequence]
   744   C0017446:Region [Geographic Area]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0150312:Found [Quantitative Concept]
   744   C0205147:Region [Spatial Concept]
   744   C0522505:Upstream [Spatial Concept]
   711 E C0243095:Find [Finding]
Processing 00000000.tx.86: Also, the overall GC content of the 6.7 kb sequence was 48.5%, which is slightly higher than what is expected on average (40%). 

Phrase: "Also,"

Phrase: "the overall GC content of the 6.7 kb sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "48.5%,"

Phrase: "which"

Phrase: "is"

Phrase: "slightly higher than what"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "is"

Phrase: "expected on average"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1510992:Average [Quantitative Concept]
   790   C1517001:Expected [Idea or Concept]
   790   C2825518:AVERAGE [Quantitative Concept]

Phrase: "(40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.87: The GC content was significantly higher (6070%) in regions upstream of exons 1A and 1B, and highest (73%) in the 100 bp region 5' of exon 1A. 

Phrase: "The GC content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "significantly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "(6070%"

Phrase: ")"

Phrase: "in regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "upstream of exons 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "highest"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C1522410:Highest [Qualitative Concept]
   966 E C0205250:High [Qualitative Concept]
   966 E C1299351:High [Qualitative Concept]
   966 E C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "(73%"

Phrase: ")"

Phrase: "in the 100 bp region 5'"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "of exon 1A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]
Processing 00000000.tx.88: Here the GpC:CpG ratio was 1:1 because of the presence of CpG islands representing SP1 recognition sites. 

Phrase: "Here"

Phrase: "the GpC:CpG ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 because of the presence of CpG islands"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0282523:CpG Islands [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0022130:Islands [Geographic Area]
   744   C0056912:CpG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C2827734:1+ [Quantitative Concept]
   744   C2981698:1+ [Classification]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "SP1 recognition sites."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0205145:Sites [Spatial Concept]
   827   C0524637:Recognition [Mental Process]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.89: All these features are typical for promoters of housekeeping genes corroborating previous findings showing ubiquitous expression of PSEN1 (13). 

Phrase: "All"

Phrase: "these features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "are"

Phrase: "typical for promoters of housekeeping genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3538928:Typical [Qualitative Concept]

Phrase: "corroborating"

Phrase: "previous findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "ubiquitous expression of PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.90: Next, we systematically screened 3.5 kb of upstream sequences by PCRSSCP analysis and found four novel polymorphisms upstream of exon 1A: two simple base changes (1789GA and 2154GA) and two complex polymorphisms (a T-stretch at 2319Tn and an insertion/deletion at 2823I/D). 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we systematically"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "3.5 kb of upstream sequences"

Phrase: "by PCRSSCP analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "found four novel polymorphisms upstream of exon 1A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "two simple base changes"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   812   C0002055:base [Inorganic Chemical]
   812   C0178499:Base [Chemical Viewed Functionally]
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   812   C1880279:Base [Biomedical or Dental Material]
   779 E C1705241:Change [Quantitative Concept]
   741 E C0205112:Basal [Spatial Concept]
   729 E C0016617:Foundation [Organization]
   729 E C1626935:Bases [Quantitative Concept]

Phrase: "(1789GA"

Phrase: "and"

Phrase: "2154GA"

Phrase: ")"

Phrase: "and"

Phrase: "two complex polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(a T-stretch at 2319Tn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "an insertion/deletion at 2823I/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "D)."
Processing 00000000.tx.91: When we compared our data with the sequence AF109907 published in GenBank, five differences were observed in the 6.7kb upstream sequence, of which three werein the 3.5 kb systematically screened by us. 

Phrase: "When"

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "our data with the sequence AF109907"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "published in GenBank,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034037:Published [Occupational Activity]
   790   C0598211:GenBank [Intellectual Product]
   790   C1704324:Published [Intellectual Product]

Phrase: "five differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed in the 6.7kb upstream sequence, of which three werein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0205449:Three [Quantitative Concept]
   738   C0522505:Upstream [Spatial Concept]
   738   C1441672:Observed [Functional Concept]
   738   C1519249:Sequence [Functional Concept]

Phrase: "the 3.5 kb systematically"

Phrase: "screened by us."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]
Processing 00000000.tx.92: Two of these represent the poly- morphisms 1789GA and 2319Tn. 

Phrase: "Two of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the poly- morphisms 1789GA"

Phrase: "and"

Phrase: "2319Tn."
Processing 00000000.tx.93: The other three (179C, 3744insT and 4853A) are most likely to be sequencing errors in AF109907 since: (i) they are located in regions that we sequenced atleast twice; 

Phrase: "The"

Phrase: "other three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "(179C,"

Phrase: "3744insT"

Phrase: "and"

Phrase: "4853A"

Phrase: ")"

Phrase: "are"

Phrase: "most likely to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0750501:most likely [Idea or Concept]
   827   C0205393:Most [Quantitative Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   755 E C0033204:Likelihood [Quantitative Concept]

Phrase: "be"

Phrase: "sequencing errors in AF109907 since"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1554168:Sequence error [Idea or Concept]
   760   C0743559:errors [Qualitative Concept]
   726 E C1608199:Error [Functional Concept]

Phrase: ":"

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "they"

Phrase: "are"

Phrase: "located in regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "atleast twice"

Phrase: ";"
Processing 00000000.tx.94: and (ii) we could not confirm their presence by PCRRFLP analysis of 10 unrelated individuals. 

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "their presence by PCRRFLP analysis of 10 unrelated individuals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.95: We analysed the novel polymorphisms, except 2319Tn, in the EOAD cases and controls. 

Phrase: "We"

Phrase: "analysed"

Phrase: "the novel polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "except 2319Tn,"

Phrase: "in the EOAD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]
   708   C0679245:early disease [Temporal Concept]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.96: The 2154GA and 2823I/D polymorphisms are in nearly complete linkage disequilibrium (P< 6.1015) with the 48CT polymorphism that we previously identified (3). 

Phrase: "The 2154GA"

Phrase: "and"

Phrase: "2823I/D polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are in nearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "(P< 6.1015"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "with the 48CT polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "we previously"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.97: Also, strong linkage disequilibrium was found between the PSEN1 intron 8 and 48CT (P=0.001). 

Phrase: "Also,"

Phrase: "strong linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "found between the PSEN1 intron 8"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   748   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0150312:Found [Quantitative Concept]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   714 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "48CT"

Phrase: "(P=0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.98: The 2823D and 2154G alleles co-existed with the 48C risk allele. 

Phrase: "The 2823D"

Phrase: "and"

Phrase: "2154G alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "co-existed with the 48C risk allele."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002085:Allele [Gene or Genome]
   748   C0035647:Risk [Qualitative Concept]
   714   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.99: As a result, the genetic association analysis of these two polymorphisms gave almost identical ORs of 3.0 and 2.9, respectively. 

Phrase: "As a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "the genetic association analysis of these two polymorphisms"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0679560:genetic analysis [Laboratory Procedure]
   767   C0796344:Genetic Analysis [Laboratory Procedure]
   750   C0796451:polymorphism analysis [Diagnostic Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "almost identical ORs of 3.0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "2.9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "respectively."
Processing 00000000.tx.100: The 1789GA polymorphism was not associated with EOAD, suggesting that it arose more recently in history on the risk haplotype. 

Phrase: "The 1789GA polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with EOAD,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1833334:Early-onset [Finding]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "arose"

Phrase: "more recently in history"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0205172:More [Functional Concept]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C0332185:Recently [Temporal Concept]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "on the risk haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.101: The association with multiple markers in the region upstream of PSEN1 described in this study is caused mainly by patients homozygous for the risk haplotype (48C/2154G/2823D). 

Phrase: "The association with multiple markers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "upstream of PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "described in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1552738:described [Idea or Concept]
   770   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "mainly by patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "homozygous for the risk haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "(48C/2154G/2823D"

Phrase: ")."
Processing 00000000.tx.102: In homozygous patients the effect of a PSEN1 promoter polymorphism may lead to important changes in PSEN1 expression levels contributing to the development of AD pathophysiology. 

Phrase: "In homozygous patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "the effect of a PSEN1 promoter polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "lead to important changes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in PSEN1 expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "contributing to the development of AD pathophysiology."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0002395:Alzheimers disease [Disease or Syndrome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0031847:pathophysiology [Functional Concept]
   744   C0243107:development [Physiologic Function]
   744   C0277785:Pathophysiology [Qualitative Concept]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   744   C1880177:Contributing [Activity]
Processing 00000000.tx.103: Since all three polymorphisms associated with an increased risk for EOAD are located in the regulatory region of PSEN1, each one separately or together may be influencing PSEN1 expression levels. 

Phrase: "Since"

Phrase: "all three polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with an increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for EOAD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "located in the regulatory region of PSEN1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0220905:regulatory [Regulation or Law]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   744   C1704735:Regulatory [Conceptual Entity]

Phrase: "each one separately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "influencing PSEN1 expression levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C3244092:expression level [Idea or Concept]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.104: Moreover, all three polymorphisms alter predicted binding properties of potential transcription factor binding sites. 

Phrase: "Moreover,"

Phrase: "all three polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "predicted binding properties of potential transcription factor binding sites."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   742   C0871161:properties [Qualitative Concept]
   742   C1292721:properties [Functional Concept]
   708 E C1882134:Property [Conceptual Entity]
   708 E C2347695:Property [Entity]
Processing 00000000.tx.105: The 48CT alters the matrix similarity of three transcription factor binding sites: c-myb, Th1/E47 and zinc finger protein with interaction domain (ZID) (Fig. 1B). 

Phrase: "The 48CT"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the matrix similarity of three transcription factor binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similarity [Qualitative Concept]

Phrase: ":"

Phrase: "c-myb,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751993:c myb [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Th1/E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1336596:E47 [Gene or Genome]

Phrase: "and"

Phrase: "zinc finger protein with interaction domain"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C1823901:ZINC FINGER PROTEIN WITH INTERACTION DOMAIN [Gene or Genome]
   820   C0080347:Zinc Finger Domain [Amino Acid Sequence]
           Zinc Finger
   820   C1956034:Protein Interaction Domain [Spatial Concept]
   783   C0162808:Protein Domain [Spatial Concept]
   783   C0872079:interaction protein [Molecular Function]
   783   C1514562:Protein Domain [Amino Acid Sequence]
   753   C0016129:Finger [Body Location or Region]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1281584:Finger [Body Part, Organ, or Organ Component]
   753   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "(ZID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823901:ZID [Gene or Genome]

Phrase: ")"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: The matrixsimilarity of c-myb at position 57 is decreased from 0.857 for 48C to 0.853 for 48T, suggesting better binding of the transcription factor to the C allele. 

Phrase: "The matrixsimilarity of c-myb"

Phrase: "at position 57"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "is"

Phrase: "decreased from 0.857"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "for 48C"

Phrase: "to 0.853"

Phrase: "for 48T,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "better"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "binding of the transcription factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   844   C1149367:transcription factor binding [Genetic Function]
   806   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040649:Transcription [Genetic Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "to the C allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.107: The binding of Th1/E47 is predicted to be less strong for 48C (0.882 versus 0.909 for 48T). 

Phrase: "The binding of Th1/E47"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "less strong for 48C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442821:Strong [Qualitative Concept]

Phrase: "(0.882"

Phrase: "versus"

Phrase: "0.909 for 48T"

Phrase: ")."
Processing 00000000.tx.108: E47 is a basic helixloophelix transcription factor, which is expressed in various tissues including brain. 

Phrase: "E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "is"

Phrase: "a basic helixloophelix transcription factor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "is"

Phrase: "expressed in various tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040300:Tissues [Tissue]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.109: In brain, E47 forms a complex with brain-specific proteins and is implicated in the development and maintenance of the mammalian nervous system (1517). 

Phrase: "In brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a complex with brain-specific proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1523872:protein complex [Cell Component]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "is"

Phrase: "implicated in the development"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "maintenance of the mammalian nervous system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0024501:Maintenance [Activity]

Phrase: "(1517"

Phrase: ")."
Processing 00000000.tx.110: The binding site for ZID is only present for the T allele. 

Phrase: "The binding site for ZID"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005456:Binding Site [Receptor]
   806   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "present for the T allele."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.111: In the case of 2823I/D, the last 10 nucleotides of the 13 bp insertion sequence are identical to the 10 nucleotides preceding the insertion site. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of 2823I/D,"

Phrase: "the last 10 nucleotides of the 13 bp insertion sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0004793:Nucleotide Sequence [Nucleotide Sequence]
   739   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "identical to the 10 nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "the insertion site."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0449682:Insertion site [Spatial Concept]
  1000   C1705686:Insertion Site [Nucleotide Sequence]
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0205145:Site [Spatial Concept]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1515974:Site [Body Location or Region]
   861   C1883719:Insertion [Functional Concept]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.112: These 10 nucleotides contain an Ets-1 binding site, although the sequence of the core-binding region does not match the consensus sequence completely (0.926 core similarity/0.888 matrix similarity). 

Phrase: "These 10 nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an Ets-1 binding site,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "although"

Phrase: "the sequence of the core-binding region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "match"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:match [Research Activity]
  1000   C1708943:Match [Qualitative Concept]

Phrase: "the consensus sequence completely"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0079160:Consensus Sequence [Nucleotide Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0376298:Consensus [Social Behavior]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "(0.926 core similarity/0.888 matrix similarity"

Phrase: ")."
Processing 00000000.tx.113: However, it is possible that the two Ets-1 sites in the insertion allele 2823I exert a cooperative binding effect and that deletion of one Ets-1 in the 2823D risk allele decreases PSEN1 expression by >2-fold. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the two Ets-1 sites in the insertion allele 2823I"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   741   C0449682:Insertion site [Spatial Concept]
   741   C1705686:Insertion Site [Nucleotide Sequence]
   739   C0205145:Sites [Spatial Concept]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a cooperative binding effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "that deletion of one Ets-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "in the 2823D risk allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "PSEN1 expression by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ">2-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.114: Also, the Ets-1 sites may interact with the Ets site at position 40 influencing basal promoter activity (18). 

Phrase: "Also,"

Phrase: "the Ets-1 sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
   734   C0812201:ETS-1 [Gene or Genome]

Phrase: "may"

Phrase: "interact with the Ets site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "at position 40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0439509:/40 [Temporal Concept]
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "influencing"

Phrase: "basal promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.115: The core similarity of the binding sequence of GKLF at the 2154GA is decreased from 1 to 0.885 when the 2154G risk allele is present. 

Phrase: "The core similarity of the binding sequence of GKLF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1710052:Sequence Similarity [Quantitative Concept]
   742   C2348205:Similarity [Qualitative Concept]

Phrase: "at the 2154GA"

Phrase: "is"

Phrase: "decreased from 1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "to 0.885"

Phrase: "when"

Phrase: "the 2154G risk allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.116: GKLF belongs to a family of tissue-specific proteins, some of which were shown to influence transcriptional activation by SP1 (19). 

Phrase: "GKLF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416660:GKLF [Gene or Genome]
  1000   C2346610:GKLF [Gene or Genome]

Phrase: "belongs to a family of tissue-specific proteins,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C1955394:Tissue specific [Body Substance]
   750   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   750   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0015576:Family [Family Group]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040300:Tissue [Tissue]
   744   C0205369:Specific [Qualitative Concept]
   744   C1547928:Tissue [Intellectual Product]
   744   C1552740:specific [Intellectual Product]
   744   C1704727:Family [Conceptual Entity]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "transcriptional activation by SP1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0162493:Transcriptional Activation [Genetic Function]
   770   C1879547:Activation [Activity]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.117: Since multiple SP1 sites are present in the PSEN1 regulatory region, a comparable brain-specific scenario may be implicated. 

Phrase: "Since"

Phrase: "multiple SP1 sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "present in the PSEN1 regulatory region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "a comparable brain-specific scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0683579:scenario [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "implicated."
Processing 00000000.tx.118: Another possibility is that it is not the polymorphisms per se that are biologically relevant, but that they are landmarks for other functionally more important variations in the PSEN1 regulatory region. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "per se"

Phrase: "that"

Phrase: "are"

Phrase: "biologically relevant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "but"

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "landmarks for other functionally more important variations"

Phrase: "in the PSEN1 regulatory region."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.119: In this context, it is interesting that we found two differentsequence variations in EOAD patients not present in controls: 280CG and 2818AG. 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "that"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "two differentsequence variations in EOAD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:variations [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "280CG"

Phrase: "and"

Phrase: "2818AG."
Processing 00000000.tx.120: Both patients were homozygous for the risk haplotype but heterozygous for the mutation. 

Phrase: "Both patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "homozygous for the risk haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "but"

Phrase: "heterozygous for the mutation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygous [Organism Attribute]
Processing 00000000.tx.121: The mutations were present in patients with onset ages of 63 and 56 years, respectively, and a first degree positive family history of disease, but no family members were available for segregation studies. 

Phrase: "The mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "present in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "with onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "ages of 63"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "56 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "respectively,"

Phrase: "and"

Phrase: "a first degree positive family history of disease,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   833   C0850707:family history of disease [Finding]
           disease family history
   772   C0683519:History of diseases [Finding]
           disease history
   770   C0241889:Family history [Finding]
   770   C1705495:Family History [Idea or Concept]
   767   C0344339:disease family [Finding]
   744   C0015576:Family [Family Group]
   744   C0019664:History [Occupation or Discipline]
   744   C0019665:history [Intellectual Product]
   744   C0262512:History, NOS [Organism Attribute]
   744   C0262926:History [Finding]
   744   C1704727:Family [Conceptual Entity]
   744   C1705255:History [Conceptual Entity]
   744   C2004062:History [Finding]
   731 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "but"

Phrase: "no family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]

Phrase: "were"

Phrase: "available for segregation studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]
Processing 00000000.tx.122: We studied the effect of 280CG located in the proximal promoter region on PSEN1 promoter activity usingaluciferase reporter gene analysis and provided evidence that 280CG modifies transcriptional activity of the PSEN1 promoter in a cell-type-specific manner. 

Phrase: "We"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of 280CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "located in the proximal promoter region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017446:Region [Geographic Area]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205107:Proximal [Spatial Concept]
   753   C0205147:Region [Spatial Concept]

Phrase: "on PSEN1 promoter activity usingaluciferase reporter gene analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   850   C0556570:Activity analysis [Therapeutic or Preventive Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   717   C1418985:Presenilin 1 Gene [Gene or Genome]

Phrase: "and"

Phrase: "provided evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that 280CG"

Phrase: "modifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "transcriptional activity of the PSEN1 promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in a cell-type-specific manner."
Processing 00000000.tx.123: In mouse neuroblastoma cells, a decrease in transcriptional activity of >30% was detected for the G allele compared with the C allele, whereas no effect was seen in human kidney cells. 

Phrase: "In mouse neuroblastoma cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1524043:Mouse Neuroblastoma [Neoplastic Process]

Phrase: "a decrease in transcriptional activity of >30%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "detected for the G allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002085:Allele [Gene or Genome]
   760   C0439267:g% [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "compared with the C allele,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002085:Allele [Gene or Genome]
   760   C1707455:Compared [Activity]

Phrase: "whereas"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "seen in human kidney cells."
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   797   C0427861:Human cells [Laboratory or Test Result]
   797   C0553257:cells kidney [Cell]
   760   C0007634:Cells [Cell]
   760   C0022646:Kidney [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
   760   C0205397:Seen [Qualitative Concept]
   760   C0227665:kidney [Body Part, Organ, or Organ Component]
   760   C1278978:Kidney [Body Part, Organ, or Organ Component]
   760   C1514845:KIDNEY [Tissue]
   760   C3282337:Cells [Cell]
   726 E C0042789:see [Organism Function]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1947903:See [Activity]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.124: These data suggest that 280CG alters or creates a cis element important for transcriptional activity in neuron-like cells, but not in kidney cells. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that 280CG"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a cis element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "important for transcriptional activity"

Phrase: "in neuron-like cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not in kidney cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   819   C0553257:cells kidney [Cell]
   770   C0007634:Cells [Cell]
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1518422:Not [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.125: The 280G mutation creates a potential NF1-binding site (core similarity 1/matrix similarity 0.872), which may influence the expression of PSEN1. 

Phrase: "The 280G mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a potential NF1-binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "(core similarity 1/matrix similarity 0.872"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   795   C0444669:Core [Spatial Concept]
   795   C1167518:core [Cell Component]
   795   C1704640:Matrix [Spatial Concept]
   795   C1706352:Core [Medical Device]
   795   C1706515:Matrix [Body Substance]
   795   C1882467:Core [Manufactured Object]
   795   C2348205:Similarity [Qualitative Concept]
   795   C3274653:Core [Body Substance]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "influence"

Phrase: "the expression of PSEN1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.126: It has been shown that NF-I proteins play an important role in the regulation of tissue-specific gene expression during mammalian embryogenesis (20). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that NF-I proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0069116:NF-I Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the regulation of tissue-specific gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "during mammalian embryogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.127: In conclusion, our study is the first one systematically analysingthe PSEN1 regulatory region for genetic variability contributing tothe genetic risk for AD. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first one systematically analysingthe PSEN1 regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   793   C0220905:regulatory [Regulation or Law]
   793   C1704735:Regulatory [Conceptual Entity]
   721 E C0205276:Regional [Spatial Concept]
   721 E C1947913:Regional [Spatial Concept]

Phrase: "for genetic variability contributing tothe genetic risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   895   C1517512:Genetic Risk [Quantitative Concept]
   799   C0035647:Risk [Qualitative Concept]

Phrase: "for AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.128: In addition to 48CT, whichweidentified earlier (3), we found two novel polymorphisms (2154GA and 2823I/D) associated with increased risk for developing EOAD independently ofAPOE4,and two potentially EOAD-related mutations (280CG and 2818AG). 

Phrase: "In addition to 48CT,"

Phrase: "whichweidentified earlier"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "two novel polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(2154GA"

Phrase: "and"

Phrase: "2823I/"

Phrase: "D)"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for developing EOAD independently ofAPOE4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]

Phrase: "and"

Phrase: "two potentially EOAD-related mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0026882:Mutations [Genetic Function]
   760 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(280CG"

Phrase: "and"

Phrase: "2818AG"

Phrase: ")."
Processing 00000000.tx.129: Both polymorphisms are in nearly complete linkage disequilibrium with 48CT previously associated with EOAD (3) independently of APOE4. 

Phrase: "Both polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are in nearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "linkage disequilibrium with 48CT previously"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "associated with EOAD"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1833334:Early-onset [Finding]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "independently of APOE4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]
Processing 00000000.tx.130: However, it will be important to test the polymorphisms for association in other epidemiological studies to confirm that PSEN1 is a risk gene for EOAD. 

Phrase: "However,"

Phrase: "it"

Phrase: "will"

Phrase: "be"

Phrase: "important to"

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the polymorphisms for association"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0032529:polymorphisms [Genetic Function]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in other epidemiological studies to"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0002783:Epidemiological Studies [Research Activity]
   827   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C0014508:epidemiology [Functional Concept]
   755 E C0699910:epidemiology [Health Care Activity]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "a risk gene for EOAD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0079429:A Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   739   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.131: Also, it will be of interest to determine whether the association previously observed with the intron 8 polymorphism can be explained by genetic variability of the PSEN1 promoter in LOAD. 

Phrase: "Also,"

Phrase: "it"

Phrase: "will"

Phrase: "be of interest to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C2987476:Be [Conceptual Entity]

Phrase: "determine"

Phrase: "whether"

Phrase: "the association previously"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "observed with the intron 8 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:Polymorphism [Genetic Function]
   753   C1441672:Observed [Functional Concept]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "explained by genetic variability of the PSEN1 promoter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   762   C2350877:Promoter, Genetic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0314603:Genetic [Functional Concept]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C2827666:Variability [Conceptual Entity]

Phrase: "in LOAD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]
Processing 00000000.tx.132: The genome scan in LOAD reported by Kehoe et al. 

Phrase: "The genome scan in LOAD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1517519:Genome Scan [Molecular Biology Research Technique]
   760   C0017428:Genome [Gene or Genome]
   760   C0034606:Scan [Diagnostic Procedure]
   760   C0441633:Scan [Diagnostic Procedure]
   760   C2338314:Genome [Conceptual Entity]
   760   C2826292:SCAN [Finding]

Phrase: "reported by Kehoe et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.133: (21) provided significant evidence neither for nor against the notion that PSEN1 may contribute to the risk of developing LOAD. 

Phrase: "(21"

Phrase: ")"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "significant evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "neither for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3274651:Neither [Qualitative Concept]

Phrase: "nor against the notion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028423:NOR [Geographic Area]
   770   C0028609:NOR [Cell Component]
   770   C1513854:NOR [Mammal]

Phrase: "that PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "contribute to the risk of developing LOAD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0035647:Risk [Qualitative Concept]
   748   C1550025:Load [Idea or Concept]
   748   C1704782:Load [Manufactured Object]
   748   C1708715:Load [Activity]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.134: However, the power of the linkage methods to detect genes of small effect is limited (22), and under the conditions used by Kehoe et al. 

Phrase: "However,"

Phrase: "the power of the linkage methods to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "genes of small effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "is"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and under the conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1515981:And [Idea or Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "used by Kehoe et al."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C1273517:Used by [Finding]
           used
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.135: (21) only genes of an effect size equal to or greater than APOE were detected. 

Phrase: "(21"

Phrase: ")"

Phrase: "only genes of an effect size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "equal to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205163:Equal To [Qualitative Concept]
           Equal
   833   C1549782:Equal [Idea or Concept]

Phrase: "or"

Phrase: "greater than APOE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.136: Each one of the polymorphisms and mutations involve consensus sequences of potential transcriptional regulatory elements (Fig. 1B) and therefore may modulate PSEN1 transcription. 

Phrase: "Each one of the polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "and"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "involve"

Phrase: "consensus sequences of potential transcriptional regulatory elements"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0079160:Sequences, Consensus [Nucleotide Sequence]
   757   C0314642:Regulatory sequence [Nucleotide Sequence]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0376298:Consensus [Social Behavior]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "therefore"

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "PSEN1 transcription."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040649:Transcription [Genetic Function]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]
Processing 00000000.tx.137: It will be essential to study the functionality of these transcription factor binding sites in vitro and in vivo. 

Phrase: "It"

Phrase: "will"

Phrase: "be"

Phrase: "essential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205224:Essential [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the functionality of these transcription factor binding sites"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.138: Missense mutations in PSEN1 were shown to lead to autosomal dominant EOAD by pathways depending on the production of increased amounts of the amyloidogenic peptide A42 (23), a proteolysis product of APP deposited in brain. 

Phrase: "Missense mutations in PSEN1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0599155:Mutations, Missense [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lead to autosomal dominant EOAD"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   833   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   789   C0814120:early disease onset [Disease or Syndrome]
   770   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0443147:Autosomal dominant [Intellectual Product]
   770   C1833334:Early-onset [Finding]
   767   C0277793:disease onset [Temporal Concept]
   767   C0679245:early disease [Temporal Concept]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0332162:Onset [Qualitative Concept]
   744   C0596142:autosomal [Cell Component]
   744   C1279919:Early [Temporal Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1527180:Dominant [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "depending on the production of increased amounts of the amyloidogenic peptide A42"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C1702162:peptide A42 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   736   C0033268:production [Occupational Activity]
   736   C0205217:Increased [Quantitative Concept]
   736   C0442805:Increased [Functional Concept]
   736   C1265611:amounts [Quantitative Concept]
   703   C0725813:depend [Medical Device]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a proteolysis product of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "deposited in brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C0333562:deposited [Functional Concept]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.139: Also, 50% antisense inhibition of PSEN1 expression in cultured cells resulted in increased A42 production (24). 

Phrase: "Also,"

Phrase: "50% antisense inhibition of PSEN1 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "resulted in increased A42 production"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033268:production [Occupational Activity]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.140: On the other hand, in neuronal cell cultures derived from PSEN1 deficient mice, APP processing into A peptides was prevented (25). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "in neuronal cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0007585:Cell Cultures [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Cultures [Idea or Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "derived from PSEN1 deficient mice,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C3657569:presenilin 1, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PRESENILIN 1 [Gene or Genome]
   753   C0011155:Deficient [Functional Concept]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   753   C1441547:Derived [Qualitative Concept]
   753   C1636779:% deficient [Quantitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "APP processing into A peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.141: Together, these observations suggest that variable expression levels of PSEN1 may modulate A production. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that variable expression levels of PSEN1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C1868500:Variable expression [Finding]
   757   C0456947:Level 1 [Intellectual Product]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Levels [Qualitative Concept]
   745   C3244092:expression level [Idea or Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.142: Our finding that the 280G mutation, creating a potential NF1-binding site, decreases PSEN1 transcriptional activity in neuroblastoma cells by 30%, suggests that the increased risk associated with PSEN1 can be explained by decreased PSEN1 expression. 

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the 280G mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "a potential NF1-binding site,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "PSEN1 transcriptional activity in neuroblastoma cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "by 30%,"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   861   C0035647:Risk [Qualitative Concept]
   861   C0205217:Increased [Quantitative Concept]
   861   C0442805:Increased [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "associated with PSEN1"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "can"

Phrase: "be"

Phrase: "explained by decreased PSEN1 expression."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PRESENILIN 1 [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   719 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.143: However, it is important to note that the 280G mutation appeared in the heterozygous state although the patient was homozygous for the risk haplotype. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the 280G mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "appeared in the heterozygous state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0019425:Heterozygous [Organism Attribute]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
   726   C0700364:APPEAR [Qualitative Concept]

Phrase: "although"

Phrase: "the patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "was"

Phrase: "homozygous for the risk haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]
Processing 00000000.tx.144: Therefore, more data on the functionality of the PSEN1 promoter are needed before concluding that altered PSEN1 transcription contributes to disease risk. 

Phrase: "Therefore,"

Phrase: "more data on the functionality of the PSEN1 promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1511726:Data [Idea or Concept]
   739   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "concluding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that altered PSEN1 transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]

Phrase: "contributes to disease risk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.145: The importance of these studies is demonstrated by recent findings of polymorphisms in the APOE promoter modulating risk for LOAD (26,27) by altering APOE4 expression levels (28). 

Phrase: "The importance of these studies"

Phrase: "is"

Phrase: "demonstrated by recent findings of polymorphisms"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0032529:polymorphisms [Genetic Function]
   753   C0332185:Recent [Temporal Concept]
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C1882417:Polymorphism [Qualitative Concept]
   719 E C2825141:Finding [Finding]

Phrase: "in the APOE promoter modulating risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035647:Risk [Qualitative Concept]

Phrase: "for LOAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "(26,"

Phrase: "27"

Phrase: ")"

Phrase: "by altering APOE4 expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.146: Also, contribution of genetic variability in the APP promoter to increased risk for LOAD was recently suggested (29), possibly by increasing APP expression leading to increased A production as in Downs syndrome cases. 

Phrase: "Also,"

Phrase: "contribution of genetic variability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "in the APP promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "to increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   861   C0035647:Risk [Qualitative Concept]
   861   C0205217:Increased [Quantitative Concept]
   861   C0442805:Increased [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "for LOAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "possibly by increasing APP expression"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1171362:protein expression [Genetic Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0442808:Increasing [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   748   C2362652:Possibly [Qualitative Concept]

Phrase: "leading to increased"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   841   C0861064:increased lead [Finding]
   790   C0205217:Increased [Quantitative Concept]
   790   C0332152:Leading [Temporal Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "as in Downs syndrome cases."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   760   C0039082:Syndrome [Disease or Syndrome]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.147: Together, these studies suggest an important role for variability in regulatory elements in the genetic predisposition for developing AD.  

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an important role for variability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "in the genetic predisposition"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
  1000   C0314657:Genetic Predisposition [Organism Attribute]
   861   C0012655:Predisposition [Clinical Attribute]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0220898:Predisposition [Organism Attribute]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   789 E C0231203:Predisposed [Functional Concept]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "for developing AD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.148: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Subjects Patients were derived from a population-based epidemiological study of EOAD within metropolitan Rotterdam and the four northern provinces of The Netherlands (30). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "derived from a population-based epidemiological study of EOAD"
Meta Candidates (Total=26; Excluded=3; Pruned=0; Remaining=23)
   790   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   767   C1709599:Population Based Study [Research Activity]
   766   C0814120:early disease onset [Disease or Syndrome]
   753   C0002395:Alzheimers disease [Disease or Syndrome]
   753   C0002783:Epidemiological Study [Research Activity]
   753   C1833334:Early-onset [Finding]
   751   C0277793:disease onset [Temporal Concept]
   751   C0679245:early disease [Temporal Concept]
   751   C0681876:Population Study [Research Activity]
   751   C2348561:Study Population [Population Group]
   743   C0699910:Study of epidemiology [Health Care Activity]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   736   C0032659:Population [Quantitative Concept]
   736   C0332162:Onset [Qualitative Concept]
   736   C0557651:Study [Manufactured Object]
   736   C1257890:Population [Population Group]
   736   C1279919:Early [Temporal Concept]
   736   C1441547:Derived [Qualitative Concept]
   736   C1527178:Based [Functional Concept]
   736   C1705938:Based [Idea or Concept]
   736   C2603343:Study [Research Activity]
   736   C3245521:derived [Idea or Concept]
   703 E C0002055:base [Inorganic Chemical]
   703 E C0178499:Base [Chemical Viewed Functionally]
   703 E C1880279:Base [Biomedical or Dental Material]

Phrase: "within metropolitan Rotterdam"

Phrase: "and"

Phrase: "the four northern provinces of The Netherlands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1514578:Province [Geographic Area]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.149: Blood samples for DNA extraction were collected from 102 (52%) of the participating patients. 

Phrase: "Blood samples for DNA extraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0178913:blood samples [Body Substance]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected from 102"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "(52%"

Phrase: ")"

Phrase: "of the participating patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.150: The mean age at onset of the patients was 56.7  5.4 years and the mean age at the time of the study was 634.4 years. 

Phrase: "The mean age at onset of the patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   744   C0001779:Age [Organism Attribute]
   744   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "56.7  5.4 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "the mean age at the time of the study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "634.4 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.151: Patients were compared with an age- and sex-matched control series (n = 118; mean age 63  4.4 years) that was drawn randomly from the Rotterdam Study (3032). 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "compared with an age-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   770   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "sex-matched control series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "(n = 118"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; mean age 63  4.4 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   876   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "that"

Phrase: "was"

Phrase: "drawn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013113:Draw [Intellectual Product]

Phrase: "randomly from the Rotterdam Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "(3032"

Phrase: ")."
Processing 00000000.tx.152: Based on family history up to two degrees, these subjects were not related. 

Phrase: "Based on family history"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   833   C0241889:Family history [Finding]
   833   C1705495:Family History [Idea or Concept]
   770   C0015576:Family [Family Group]
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1527178:Based [Functional Concept]
   770   C1704727:Family [Conceptual Entity]
   770   C1705255:History [Conceptual Entity]
   770   C1705938:Based [Idea or Concept]
   770   C2004062:History [Finding]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "up to two degrees,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0449286:degrees [Quantitative Concept]
   861   C0542560:degrees [Intellectual Product]
   827 E C0441889:Degree [Qualitative Concept]
   827 E C1561545:degree [Quantitative Concept]
   827 E C2348088:Degree [Quantitative Concept]

Phrase: "these subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.153: None of the control subjects showed symptoms of dementia and none had cognitive test scores suspect for dementia (30,32). 

Phrase: "None of the control subjects"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0243148:control [Qualitative Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "symptoms of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683368:symptoms [Functional Concept]
   790   C1457887:Symptoms [Sign or Symptom]

Phrase: "and"

Phrase: "none"

Phrase: "had"

Phrase: "cognitive test scores"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0237855:Test scores [Qualitative Concept]
   884 E C0237856:test score [Educational Activity]
   827   C0449820:Scores [Quantitative Concept]

Phrase: "suspect for dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C0750491:suspect [Idea or Concept]
   790   C1571873:Suspect [Idea or Concept]

Phrase: "(30,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.154: Sequencing of the PSEN1 5' upstream region Plasmid B22 (14) was subcloned into the pOCUS-2 vector for transposon-based genomic sequencing (Novagen, Madison, WI). 

Phrase: "Sequencing of the PSEN1 5' upstream region Plasmid B22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1553778:Sequencing [Intellectual Product]
   739   C1561491:Sequencing [Functional Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "was"

Phrase: "subcloned into the pOCUS-2 vector"

Phrase: "for transposon-based genomic sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1553778:Sequencing [Intellectual Product]
   812   C1561491:Sequencing [Functional Concept]

Phrase: "(Novagen,"

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.155: The pOCUS-2 constructs were transferred into chemically competent donor cells, which carry the transposon on an F factor, and one of the resulting colonies was mated with the recipient cells according to the manufacturers protocol. 

Phrase: "The pOCUS-2 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "transferred into chemically competent donor cells,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0013018:Donor [Population Group]
   753   C0040288:Donor [Population Group]
   753   C0086035:Competent [Qualitative Concept]
   753   C0220806:Chemically [Chemical]
   753   C0348011:transferred [Functional Concept]
   753   C1527169:Donor NOS [Finding]
   753   C3282337:Cells [Cell]
   719 E C0040671:Transfer [Mental Process]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1705822:Transfer [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "the transposon on an F factor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1257902:Transposon [Gene or Genome]

Phrase: "and"

Phrase: "one of the resulting colonies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "mated with the recipient cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C1254211:mated [Pharmacologic Substance]
   760   C1260875:Mated [Organism Function]
   760   C1709854:Recipient [Human]
   760   C3282337:Cells [Cell]
   726 E C0682323:mate [Family Group]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "according to the manufacturers protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.156: For each fragment, 96 colonies were randomly selected and stored in a 96-well plate containing LB medium supplemented with 20% glycerol. 

Phrase: "For each fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "96 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "randomly"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "and"

Phrase: "stored in a 96-well plate containing LB medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   742   C0005971:Plate [Medical Device]
   742   C0009458:Medium [Intellectual Product]
   742   C0205170:Well [Qualitative Concept]
   742   C0332256:Containing [Functional Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1139930:plate [Medical Device]
   742   C1705217:Medium [Substance]
   742   C2700400:Containing [Activity]
   742   C3146287:Well [Manufactured Object]
   742   C3244283:medium [Intellectual Product]
   742   C3537155:Plate [Manufactured Object]
   708   C1698986:Store [Functional Concept]

Phrase: "supplemented with 20% glycerol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.157: The transposition site of the different clones was mapped by colony PCR combining one of the two vector-specific primers (POCUSUP or POCUSDOWN) with a transposon-specific primer (GDIR) in separate reactions (33). 

Phrase: "The transposition site of the different clones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "mapped by colony PCR combining one of the two vector-specific primers"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   736   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   736   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0205369:Specific [Qualitative Concept]
   736   C0205447:One [Quantitative Concept]
   736   C0205448:Two [Quantitative Concept]
   736   C0439158:colony [Quantitative Concept]
   736   C0442335:Vector [Spatial Concept]
   736   C0677874:pCR [Finding]
   736   C1552740:specific [Intellectual Product]
   736   C1705099:Vector [Idea or Concept]
   736   C1947989:Colony [Cell]
   703   C0024779:Map [Manufactured Object]
   703   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   703   C0336789:Combine [Manufactured Object]
   703   C1706473:Map [Conceptual Entity]

Phrase: "(POCUSUP"

Phrase: "or"

Phrase: "POCUSDOWN"

Phrase: ")"

Phrase: "with a transposon-specific primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(GDIR"

Phrase: ")"

Phrase: "in separate reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.158: Colonies were selected based on their site of transposition and DNA was prepared for sequencing using the Wizard Plus SV Minipreps DNA Purification System (Promega, Madison, WI). 

Phrase: "Colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439158:colonies [Quantitative Concept]
   966 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "based on their site of transposition"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C2945843:Site of [Qualitative Concept]
   753   C0040674:Transposition [Therapeutic or Preventive Procedure]
   753   C0040759:Transposition [Congenital Abnormality]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1820371:transposition [Genetic Function]
   753   C2825164:Site [Spatial Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared for sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Wizard Plus SV Minipreps DNA Purification System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   795   C0449913:System [Functional Concept]
   795   C1553451:System [Manufactured Object]
   795   C1704459:System [Medical Device]
   724 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.159: Plasmid sequencing was performed using the Thermo Sequenase II Dye Terminator Cycle Sequencing kit (Amersham Life Science, Cleveland, OH) according to the suppliers protocol using primers GD1 and GD2 (33). 

Phrase: "Plasmid sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Thermo Sequenase II Dye Terminator Cycle Sequencing kit (Amersham Life Science,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   801   C0005526:Science, Life [Occupation or Discipline]
   788   C0036397:Science [Occupation or Discipline]
   788   C0376558:Life [Idea or Concept]
   705 E C0595998:lives [Finding]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH) according to the suppliers protocol"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0220853:OH- [Element, Ion, or Isotope]
   753   C0442711:Protocol [Intellectual Product]
   753   C0470689:Suppliers [Health Care Related Organization]
   753   C0680240:according [Social Behavior]
   753   C1507394:Protocol [Intellectual Product]
   753   C1522729:Protocol [Intellectual Product]
   753   C2348563:Protocol [Intellectual Product]
   719 E C0470690:supplier [Health Care Related Organization]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers GD1"

Phrase: "and"

Phrase: "GD2"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.160: The sequences were assembled using the Lasergene software for Windows (DNASTAR, Madison, WI). 

Phrase: "The sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "assembled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706853:Assemble [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Lasergene software for Windows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(DNASTAR,"

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.161: Gaps in the sequence were completed by targeted cycle sequencing using primers directed against sequences flanking the gaps. 

Phrase: "Gaps in the sequence"

Phrase: "were"

Phrase: "completed by targeted cycle sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205197:COMPLETED [Qualitative Concept]
   760   C1511572:Cycle [Temporal Concept]
   760   C1521840:Targeted [Functional Concept]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "directed against sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0162326:Sequences [Nucleotide Sequence]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756   C0439851:Direct [Qualitative Concept]
   756 E C1519249:Sequence [Functional Concept]
   756   C1947931:Direct [Qualitative Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the gaps."
Processing 00000000.tx.162: DNA analysis Standard PCR was performed using 16 overlapping primer sets covering the 3.5 kb sequence upstream of exon 1B. 

Phrase: "DNA analysis Standard PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0200931:analysis pcr [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "16 overlapping primer sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1705195:Set [Conceptual Entity]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "the 3.5 kb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "sequence upstream of exon 1B."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0450345:1B [Intellectual Product]
   760   C0522505:Upstream [Spatial Concept]
   760   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.163: Two additional primer sets were designed to analyse the two sequence differences 3744insT and 4853GA. 

Phrase: "Two additional primer sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyse"

Phrase: "the two sequence differences 3744insT"

Phrase: "and"

Phrase: "4853GA."
Processing 00000000.tx.164: In the SSCP analyses, heat-denatured and renatured PCR products were electrophoresed on precast ExcelGel gels (Pharmacia Biotech, Uppsala, Sweden) for 3.5 h at 600 V using the MultiPhorII electrophoresis system (Pharmacia Biotech) and visualized by silver staining. 

Phrase: "In the SSCP analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1519159:SSCP Analysis [Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "heat-denatured"

Phrase: "and"

Phrase: "renatured PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed on precast ExcelGel gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0017243:Gels [Biomedical or Dental Material]
   726   C0013855:electrophorese [Laboratory Procedure]
   726 E C1382104:Gel [Substance]

Phrase: "(Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "for 3.5 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0041119:3 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "at 600 V"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MultiPhorII electrophoresis system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "and"

Phrase: "visualized by silver staining."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1293950:Silver Staining [Laboratory Procedure]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.165: Products with aberrant SSCP patterns were sequenced as described above. 

Phrase: "Products with aberrant SSCP patterns"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "sequenced as described above."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1552738:described [Idea or Concept]
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.166: Polymorphisms were analysed by restriction enzyme digestion of the PCR products amplified from genomic DNA, when they produced an RFLP. 

Phrase: "Polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "analysed by restriction enzyme digestion of the PCR products"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0012238:Digestion [Organism Function]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0443288:Restriction [Functional Concept]
   742   C0677874:pCR [Finding]
   742   C1514468:Products [Entity]
   742   C2349986:Digestion [Research Activity]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "amplified from genomic DNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0017428:Genomic [Gene or Genome]
   770   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "when"

Phrase: "they"

Phrase: "produced"

Phrase: "an RFLP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035268:RFLP [Clinical Attribute]
Processing 00000000.tx.167: In case no RFLP was present, mismatch primers were designed or samples were analysed by PCRSSCP analysis. 

Phrase: "In case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "no RFLP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035268:RFLP [Clinical Attribute]

Phrase: "was"

Phrase: "present, mismatch primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "or"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analysed by PCRSSCP analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.168: Fragments were separated on a 1.53% agarose gel and visualized on an ultraviolet trans-illuminator after ethidium bromide staining. 

Phrase: "Fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "separated on a 1.53% agarose gel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1706746:Agarose Gel [Research Device]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized on an ultraviolet trans-illuminator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0234621:Visualized [Functional Concept]
   753   C1532472:Ultraviolet [Qualitative Concept]
   753   C2826298:TRANS [Idea or Concept]

Phrase: "after ethidium bromide staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.169: Alternatively, fragments were separated on precast ExcelGel gels and visualized by silver staining. 

Phrase: "Alternatively,"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "separated on precast ExcelGel gels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by silver staining."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1293950:Silver Staining [Laboratory Procedure]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.170: Statistical analysis Allele and genotype distributions in patients and controls, excluding the six patients with PSEN1 mutations, were compared using Fishers exact test (34). 

Phrase: "Statistical analysis Allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "and"

Phrase: "genotype distributions in patients"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0037775:Distributions [Spatial Concept]
   737 E C0520511:distribution [Idea or Concept]
   737 E C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the six patients with PSEN1 mutations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fishers exact test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   988   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.171: HardyWeinberg equilibrium and linkage disequilibrium were tested using the HWE and EH programs as described by Terwilliger and Ott (34). 

Phrase: "HardyWeinberg equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014653:Equilibrium [Organism Function]
   861   C1547026:Equilibrium [Quantitative Concept]

Phrase: "and"

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the HWE"

Phrase: "and"

Phrase: "EH programs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0376691:Programs [Intellectual Product]
   861   C3484370:Programs [Functional Concept]
   827 E C1709697:Program [Conceptual Entity]
   827 E C2728259:Program [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Terwilliger"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Ott (34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1423088:OTT [Gene or Genome]
   861   C3273338:OTT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.172: Since the markers tested were in strong linkage disequilibrium, adjustment for multiple testing is not straightforward, as statistical tests are not independent. 

Phrase: "Since"

Phrase: "the markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "were in strong linkage disequilibrium,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0442821:Strong [Qualitative Concept]

Phrase: "adjustment for multiple testing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0376209:Adjustment [Individual Behavior]
   770   C0456081:Adjustment [Functional Concept]
   770   C0683269:adjustment [Individual Behavior]

Phrase: "is"

Phrase: "not straightforward,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1272701:Straightforward [Qualitative Concept]

Phrase: "as"

Phrase: "statistical tests"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0237913:statistical tests [Intellectual Product]
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "are"

Phrase: "not independent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085862:Independent [Idea or Concept]
   861   C1299583:Independent [Finding]
Processing 00000000.tx.173: Therefore, exact P values were calculated. 

Phrase: "Therefore,"

Phrase: "exact P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C1709380:P-Value [Quantitative Concept]
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.174: The strength of association between alleles or genotypes and EOAD was evaluated with the OR presented with 95% confidence intervals. 

Phrase: "The strength of association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237897:Strength [Quantitative Concept]
   770   C0808080:Strength [Idea or Concept]
   770   C1705922:Strength [Qualitative Concept]

Phrase: "between alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "or"

Phrase: "genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "EOAD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "evaluated with the OR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0220825:Evaluated [Functional Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "presented with 95% confidence intervals."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0009667:Confidence Intervals [Quantitative Concept]
   760   C0237529:Confidence [Mental Process]
   760   C0449450:Presented [Idea or Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1704725:Confidence [Qualitative Concept]
   760   C1704726:Confidence [Mental Process]
   726 E C0150312:Present [Quantitative Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.175: Construction of reporter plasmids The PSEN1 5' upstream region from 323 to +1231 was cloned into the promoterless pGL3-basic vector (Promega) upstream of the firefly luciferase gene. 

Phrase: "Construction of reporter plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "The PSEN1 5' upstream region from 323 to +1231"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1883644:Upstream Region [Nucleotide Sequence]
   739   C0017446:Region [Geographic Area]
   739   C0205147:Region [Spatial Concept]
   739   C0522505:Upstream [Spatial Concept]

Phrase: "was"

Phrase: "cloned into the promoterless pGL3-basic vector"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0009013:cloned [Cell]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1527178:Basic [Functional Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1854336:PGL3 [Disease or Syndrome]
   748   C3273620:PGL3 [Gene or Genome]
   714 E C1522642:Clone [Tissue]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "upstream of the firefly luciferase gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1334435:Luciferase Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.176: The Quick-change in vitro mutagenesis kit (Stratagene, La Jolla, CA) was used to introduce the 280G mutation using primer 5'-ATTTAGGATGGCCATGGCTTGTATGCCGGGAGAAGCACACGCTG-3' and its reverse complement. 

Phrase: "The Quick-change in vitro mutagenesis kit (Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "the 280G mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer 5'-ATTTAGGATGGCCATGGCTTGTATGCCGGGAGAAGCACACGCTG-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "its reverse complement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.177: A mutant clone was selected by NcoI digestion and the integrity of the complete insert was confirmed by sequence analysis as described above using vector- and PSEN1-specific primers designed for screening of the PSEN1 5' upstream region. 

Phrase: "A mutant clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "selected by NcoI digestion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0012238:Digestion [Organism Function]
   770   C2349986:Digestion [Research Activity]
   737   C1707391:Select [Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "the integrity of the complete insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205266:integrity [Qualitative Concept]
   753   C0872403:integrity [Individual Behavior]
   753   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed by sequence analysis"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0750484:Confirmed [Idea or Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1519249:Sequence [Functional Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "as"

Phrase: "described above"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "vector-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "PSEN1-specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "designed for screening of the PSEN1 5' upstream region."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C1883644:Upstream Region [Nucleotide Sequence]
   739   C0017446:Region [Geographic Area]
   739   C0205147:Region [Spatial Concept]
   739   C0220908:Screening [Health Care Activity]
   739   C0220909:screening [Functional Concept]
   739   C0522505:Upstream [Spatial Concept]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   739   C1698960:screening [Intellectual Product]
   739   C1710031:Screening [Diagnostic Procedure]
   739   C1710477:SCREENING [Research Activity]
   706   C1707689:Design [Activity]
   706   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.178: Eukaryotic cell culture and transient transfection Mouse N2A cells were propagated in a minimal essential medium with Earles salt, 10% fetal bovine serum, 2 mM L-glutamine, 200IU/ml penicillin, 200 g/ml streptomycin and 0.1 mM non-essential amino acids (Life Technologies, Gaithersburg, MD). 

Phrase: "Eukaryotic cell culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
   734   C0015161:Eukaryotic Cell [Cell]

Phrase: "and"

Phrase: "transient transfection Mouse N2A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "propagated in a minimal essential medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0205224:Essential [Qualitative Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0547040:Minimal [Qualitative Concept]
   753   C1524031:MINIMAL [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C2945599:Minimal [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]

Phrase: "with Earles salt,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0036140:Salt [Chemical Viewed Structurally]
   861   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0206136:Salt [Food,Inorganic Chemical]
   789 E C1537053:salty [Qualitative Concept]
   761 E C0678584:saltiness [Qualitative Concept]

Phrase: "10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "2 mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "200IU/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "200 g/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "0.1 mM non-essential amino acids"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   860   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   845   C0002525:Amino Acids, Essential [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812 E C2348468:Essential_Amino_Acid [Conceptual Entity]
   795   C0001128:Acids [Chemical]
   795   C0205224:Essential [Qualitative Concept]
   795   C1518422:Non [Functional Concept]
   785 E C2917660:Amino Acid [Pharmacologic Substance]
   762 E C0202406:Acid [Laboratory Procedure]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Gaithersburg,"

Phrase: "MD)."
Processing 00000000.tx.179: HEK293 cells were propagated in Optimem with 10% fetal bovine serum, 200 IU/ml penicillin and 200 g/ml streptomycin (Life Technologies). 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "propagated in Optimem"

Phrase: "with 10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "200 IU/ml penicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "200 g/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.180: For transient transfection, N2A and HEK293 cells were seeded in 6-well tissue culture dishes, at 9 x 104 and 7x105 cells/well, respectively, and allowed to recover for 24 h. 

Phrase: "For transient transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "N2A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]

Phrase: "and"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in 6-well tissue culture dishes,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   797   C0492792:DISH, TISSUE CULTURE [Medical Device]
   778   C0040284:Tissue culture [Laboratory Procedure]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0205170:Well [Qualitative Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3146287:Well [Manufactured Object]
   714   C0020498:DISH [Disease or Syndrome]
   714   C0036563:Seed [Plant]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "at 9 x 104"

Phrase: "and"

Phrase: "7x105 cells/well,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2347578:Cells/well [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "respectively,"

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover for 24 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0521108:recover [Qualitative Concept]
   770   C0564385:/h [Quantitative Concept]
   770   C2004454:recover [Organism Function]
Processing 00000000.tx.181: Cells were co-transfected with 20 ng of pRL-TK plasmid containing the herpes simplex virus thymidine kinase promoter upstream of the renilla luciferase gene (Promega) and 1 g of either one of the PSEN1 promoter constructs or one of the control plasmids, using the Lipofectamine procedure (Life Technologies) as described in the manufacturers protocol. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with 20 ng of pRL-TK plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0220928:TK [Geographic Area]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the herpes simplex virus thymidine kinase promoter upstream of the renilla luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   749   C0314621:Promoter gene [Gene or Genome]
   735   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "1 g of either one of the PSEN1 promoter constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   738   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "one of the control plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Lipofectamine procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "as"

Phrase: "described in the manufacturers protocol."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0442711:Protocol [Intellectual Product]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C2348563:Protocol [Intellectual Product]
   726   C0947322:Manufacturer [Intellectual Product]
   726   C1705426:Manufacturer [Population Group]
Processing 00000000.tx.182: Empty pGL3-basic vector was used as a negative control, pGL3-promoter plasmid containing the SV40 promoter upstream of the firefly luciferase gene (Promega) as a positive control. 

Phrase: "Empty pGL3-basic vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "used as a negative control,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "pGL3-promoter plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the SV40 promoter upstream of the firefly luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0314621:Promoter gene [Gene or Genome]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "as a positive control."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.183: Relative luciferase activity measures Transfected cells were cultured for 48 h, washed with 1 ml of phosphate-buffered saline (Life Technologies), and lysed with Passive lysis buffer (Promega). 

Phrase: "Relative luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "Transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 48 h,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "washed with 1 ml of phosphate-buffered saline"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C0439526:/mL [Quantitative Concept]
   744   C1548982:Washed [Idea or Concept]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   711 E C0441648:Wash [Activity]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "lysed with Passive lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:Lysis [Pathologic Function]
           lysed
   760   C1536403:lysis [Cell Function]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.184: Firefly luciferase activities (LAF) and renilla luciferase activities (LAR) were measured sequentially using a Dual-Luciferase reporter assay system (Promega) and a model TD-20E Luminometer (Turner Design, Sunnyvale, CA). 

Phrase: "Firefly luciferase activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1324397:firefly luciferase activity [Molecular Function]
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(LAF)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021755:LAF [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "renilla luciferase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "(LAR)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419115:LAR [Gene or Genome]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "sequentially"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Dual-Luciferase reporter assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "a model TD-20E Luminometer"

Phrase: "(Turner Design,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.185: To correct for transfection efficiency and DNA uptake, the relative luciferase activity (RLA) was calculated as: RLA = LAF/LAR. 

Phrase: "To correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for transfection efficiency"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "and"

Phrase: "DNA uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "the relative luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: ":"

Phrase: "RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "= LAF/LAR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419115:LAR [Gene or Genome]
Processing 00000000.tx.186: To compare the RLA of a sample in one cell line with another, relative RLA was calculated as a percentage of the RLA of the wild-type construct: %RLA = (RLAmt/RLAwt) x 100.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the RLA of a sample"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1151115:luciferase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in one cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "with another,"

Phrase: "relative RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1151115:luciferase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "calculated as a percentage of the RLA"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C1151115:luciferase activity [Molecular Function]
   742   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   742   C0080103:Relative [Family Group]
   742   C0205177:Activity [Functional Concept]
   742   C0205345:Relative [Qualitative Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0444686:Calculated [Functional Concept]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1547039:*Relative [Quantitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "of the wild-type construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827421:Construct [Classification]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: ":"

Phrase: "%RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "="

Phrase: "(RLAmt/RLAwt"

Phrase: ")"

Phrase: "x 100."
Processing 00000000.tx.187: ACKNOWLEDGEMENTS  We thank J. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.188: Remacle for his kind advice and inspiring discussions. 

Phrase: "Remacle for his kind advice"

Phrase: "and"

Phrase: "inspiring discussions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0557061:discussions [Therapeutic or Preventive Procedure]
   827 E C2584313:Discussion [Social Behavior]
Processing 00000000.tx.189: This work was supported by the Fund for Scientific Research-Flanders (Belgium; FWO-F), DWTC Interuniversity Attractionpoles (IUAP P4/17), the International Alzheimers Research Foundation (IARF) and grants from the Netherlands Organisation for Scientific Research (NWO), The Netherlands Institute for Health Sciences (NIHES) and the Hersenstichting Nederland (HsN). 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Fund"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0016820:Fund [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "for Scientific Research-Flanders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1875156:Flanders [Inorganic Chemical,Pharmacologic Substance]
   734   C0683933:scientific research [Research Activity]

Phrase: "(Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "; FWO-F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "DWTC Interuniversity Attractionpoles"

Phrase: "(IUAP P4/17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1539372:p4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the International Alzheimers Research Foundation (IARF)"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   804   C0016617:Foundation [Organization]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1512888:International [Idea or Concept]
   798   C2986512:Research Base [Organization]
   721 E C0002055:base [Inorganic Chemical]
   721 E C0178499:Base [Chemical Viewed Functionally]
   721 E C1626935:Bases [Quantitative Concept]
   721 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "grants from the Netherlands Organisation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0018173:Grants [Quantitative Concept]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "(NWO"

Phrase: ")"

Phrase: ","

Phrase: "The Netherlands Institute for Health Sciences (NIHES)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "and"

Phrase: "the Hersenstichting Nederland (HsN)."
Processing 00000000.tx.190: M.C. is a postdoctoral fellow and B.D. a PhD fellow of the FWO-F.  

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "a postdoctoral fellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0586917:Postdoctoral Fellow [Professional or Occupational Group]

Phrase: "and"

Phrase: "B.D."

Phrase: "a PhD fellow of the FWO-F."
Processing 00000000.tx.191: FOOTNOTES  + To whom correspondence should be addressed at: Laboratory of Molecular Genetics, Neurogenetics Group, University of Antwerp (UIA), Department of Biochemistry, Universiteitsplein 1, B-2610 Antwerpen, Belgium. 

Phrase: "FOOTNOTES  +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Laboratory of Molecular Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "Neurogenetics Group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "University of Antwerp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "(UIA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ","

Phrase: "Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Universiteitsplein 1,"

Phrase: "B-2610 Antwerpen,"

Phrase: "Belgium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]
Processing 00000000.tx.192: Tel: +32 3 8202333; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+32 3 8202333"

Phrase: ";"
Processing 00000000.tx.193: Fax: +32 3 8202541; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+32 3 8202541"

Phrase: ";"
Processing 00000000.tx.194: Email: cruts@uia.ua.ac.be  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1 Ott, A., Breteler, M.M., Van Harskamp, F., Stijnen, T. and Hofman, A. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "cruts@uia.ua.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1412573:AC [Gene or Genome]
   812   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3539770:AC [Gene or Genome]

Phrase: "be"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1423088:OTT [Gene or Genome]
   861   C3273338:OTT [Gene or Genome]

Phrase: "A.,"

Phrase: "Breteler,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Van Harskamp,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Stijnen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hofman,"

Phrase: "A."
Processing 00000000.tx.195: (1998) Incidence and risk of dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "and"

Phrase: "risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.196: The Rotterdam Study. 

Phrase: "The Rotterdam Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.197: Am. 

Phrase: "Am."
Processing 00000000.tx.198: J. 

Phrase: "J."
Processing 00000000.tx.199: Epidemiol., 147, 574580.[Abstract] 2 Slooter, A.J. and van Duijn, C.M. 

Phrase: "Epidemiol.,"

Phrase: "147,"

Phrase: "574580."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 2 Slooter,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "van Duijn,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.200: (1997) Genetic epidemiology of Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genetic epidemiology of Alzheimer disease."
Meta Candidates (Total=16; Excluded=9; Pruned=0; Remaining=7)
   806   C0872180:Genetic Epidemiology [Occupation or Discipline]
   797   C0019247:Genetic disease [Disease or Syndrome]
   760   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   760   C0014508:epidemiology [Functional Concept]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C0699910:epidemiology [Health Care Activity]
   756 E C2316203:Genetic diseases [Finding]
   756 E C2924406:Genetic diseases [Laboratory Procedure]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.201: Epidemiol. 

Phrase: "Epidemiol."
Processing 00000000.tx.202: Rev., 19, 107119.[ISI][Medline] 3 Cruts, M., van Duijn, C.M., Backhovens, H., Van den Broeck, M., Wehnert, A., Serneels, S., Sherrington, R., Hutton, M., Hardy, J., St-George Hyslop, P.H. et al. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "19,"

Phrase: "107119."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 3 Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Van den Broeck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Serneels,"

Phrase: "S."

Phrase: ","

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "St-George Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.H. et al."
Processing 00000000.tx.203: (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Estimation of the genetic contribution of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0680844:estimation [Mental Process]
   744   C0681916:Estimation [Quantitative Concept]
   744   C0750572:Estimation [Quantitative Concept]

Phrase: "and -"

Phrase: "2 mutations in a population-based study of presenile Alzheimer disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0026882:Mutations [Genetic Function]
   704 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.204: Hum. 

Phrase: "Hum."
Processing 00000000.tx.205: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.206: Genet., 7, 4351.[Abstract/Free FullText] 4 Campion, D., Flaman, J.-M., Brice, A., Hannequin, D., Dubois, B., Martin, C., Moreau, V., Charbonnier, F., Didierjean, O., Tardieu, S. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "4351."

Phrase: "[Abstract/Free FullText"

Phrase: "] 4 Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Flaman,"

Phrase: "J.-"

Phrase: "M."

Phrase: ","

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Hannequin,"

Phrase: "D."

Phrase: ","

Phrase: "Dubois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Moreau,"

Phrase: "V.,"

Phrase: "Charbonnier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Didierjean,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Tardieu,"

Phrase: "S. et al."
Processing 00000000.tx.207: (1995) Mutations of the presenilin 1 gene in families with early-onset Alzheimers disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mutations of the presenilin 1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with early-onset Alzheimers disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.208: Hum. 

Phrase: "Hum."
Processing 00000000.tx.209: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.210: Genet., 4, 23732377.[Abstract] 5 Hutton, M., Busfield, F., Wragg, M., Crook, R., Perez, T.J., Clark, R.F., Prihar, G., Talbot, C., Phillips, H., Wright, K. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "23732377."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 5 Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Busfield,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perez,"

Phrase: "T.J.,"

Phrase: "Clark,"

Phrase: "R.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Phillips,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "K. et al."
Processing 00000000.tx.211: (1996) Complete analysis of the presenilin 1 gene in early onset Alzheimers disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "analysis of the presenilin 1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in early onset Alzheimers disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.212: Neuroreport, 7, 801805.[ISI][Medline] 6 Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L. et al. 

Phrase: "Neuroreport,"

Phrase: "7,"

Phrase: "801805."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 6 Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L. et al."
Processing 00000000.tx.213: (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimers disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Segregation of a missense mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "with familial Alzheimers disease."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.214: Nature, 349, 704706.[ISI][Medline] 7 Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.-E., Jondro, P.D., Schmidt, S.D., Wang, K. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "349,"

Phrase: "704706."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 7 Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "W.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.-E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "K. et al."
Processing 00000000.tx.215: (1995) Candidate gene for the chromosome 1 familial Alzheimers disease locus. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Candidate gene for the chromosome 1 familial Alzheimers disease locus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Gene
   757   C1708726:Gene Locus [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   730   C1416989:MAL gene [Gene or Genome]
   722   C1517488:Gene Family [Gene or Genome]
Processing 00000000.tx.216: Science, 269, 973977.[ISI][Medline] 8 Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak, V.M., Enghild, J., Salvesen, G.S. and Roses, A.D. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "269,"

Phrase: "973977."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 8 Strittmatter,"

Phrase: "W.J.,"

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Pericak,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Enghild,"

Phrase: "J.,"

Phrase: "Salvesen,"

Phrase: "G.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.217: (1993) Apolipoprotein E: high-avidity binding to -amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "high-avidity binding to -amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "increased frequency of type 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in late-onset familial Alzheimer disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
  1000   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.218: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.219: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.220: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.221: USA, 90, 19771981.[Abstract] 9 van Duijn, C., de Knijff, P., Cruts, M., Wehnert, A., Havekes, L.M., Hofman, A. and Van Broeckhoven, C. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "19771981."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 9 van Duijn,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "de Knijff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Havekes,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.222: (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimers disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E4 allele in a population-based study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]

Phrase: "of early-onset Alzheimers disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.223: Nature Genet., 7, 7478.[ISI][Medline] 10 Wragg, M., Hutton, M. and Talbot, C. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "7478."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 10 Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Talbot,"

Phrase: "C."
Processing 00000000.tx.224: (1996) Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimers disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genetic association between intronic polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1328885:genetic association [Occupation or Discipline]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in presenilin-1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "late-onset Alzheimers disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.225: Alzheimers Disease Collaborative Group. 

Phrase: "Alzheimers Disease Collaborative Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
Processing 00000000.tx.226: Lancet, 347, 509512.[ISI][Medline] 11 van Duijn, C., Cruts, M., Theuns, J., Van Gassen, G., Backhovens, H., Vanden Broeck, M., Wehnert, A., Serneels, S., Hofman, A. and VanBroeckhoven, C. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "347,"

Phrase: "509512."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 11 van Duijn,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Theuns,"

Phrase: "J.,"

Phrase: "Van Gassen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vanden Broeck,"

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Serneels,"

Phrase: "S."

Phrase: ","

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "VanBroeckhoven,"

Phrase: "C."
Processing 00000000.tx.227: (1999) Genetic association of the presenilin-1 regulatory region with early-onset Alzheimers disease in a population-based sample. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genetic association of the presenilin-1 regulatory region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1328885:genetic association [Occupation or Discipline]
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with early-onset Alzheimers disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "in a population-based sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.228: Eur. 

Phrase: "Eur."
Processing 00000000.tx.229: J. 

Phrase: "J."
Processing 00000000.tx.230: Hum. 

Phrase: "Hum."
Processing 00000000.tx.231: Genet., 7, 801806.[ISI][Medline] 12 Clark, R.F., Hutton, M., Fuldner, R.A., Froelich, S., Karran, E., Talbot, C., Crook, R., Lendon, C., Prihar, G., He, C. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "801806."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 12 Clark,"

Phrase: "R.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Fuldner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Karran,"

Phrase: "E.,"

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "He,"

Phrase: "C. et al."
Processing 00000000.tx.232: (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The structure of the presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "(S182"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418985:S182 [Gene or Genome]
  1000   C2986918:S182 [Gene or Genome]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "identification of six novel mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in early onset AD families."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0344339:disease family [Finding]
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   771   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   721 E C0241888:Familial [Functional Concept]
   708   C0679245:early disease [Temporal Concept]
Processing 00000000.tx.233: Alzheimers Disease Collaborative Group. 

Phrase: "Alzheimers Disease Collaborative Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
Processing 00000000.tx.234: Nature Genet., 11, 219222.[ISI][Medline] 13 Rogaev, E.I., Sherrington, R., Wu, C., Levesque, G., Liang, Y., Rogaeva, E.A., Ikeda, M., Holman, K., Lin, C., Lukiw, W.J. et al. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "219222."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 13 Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lukiw,"

Phrase: "W.J. et al."
Processing 00000000.tx.235: (1997) Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Analysis of the 5' sequence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "genomic structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "alternative splicing of the presenilin-1 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002345:Alternative Splicing [Genetic Function]
   774   C0017365:gene splicing [Gene or Genome]
   774   C0017387:Gene Splicing [Molecular Biology Research Technique]
   748   C0035687:Splicing [Genetic Function]
   748   C2610186:splicing [Genetic Function]

Phrase: "(PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "associated with early onset Alzheimer disease."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   901   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C1833334:Early-onset [Finding]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.236: Genomics, 40, 415424.[ISI][Medline] 14 Theuns, J., Cruts, M., Del-Favero, J., Goossens, D., Dauwerse, H., Wehnert, A., den Dunnen, J.T. and Van Broeckhoven, C. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "415424."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 14 Theuns,"

Phrase: "J.,"

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Del-Favero,"

Phrase: "J.,"

Phrase: "Goossens,"

Phrase: "D."

Phrase: ","

Phrase: "Dauwerse,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "den Dunnen,"

Phrase: "J.T."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.237: (1999) Determination of the genomic organization of human presenilin 1 by fiber-FISH analysis and restriction mapping of cloned DNA. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Determination of the genomic organization of human presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1148554:determination [Laboratory Procedure]

Phrase: "by fiber-FISH analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1517169:Fiber FISH [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "restriction mapping of cloned DNA."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0035269:Restriction Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   797   C1328871:DNA mapping [Intellectual Product]
   797   C1749889:DNA restriction [Genetic Function]
   760   C0443288:Restriction [Functional Concept]
   760   C1283195:Mapping [Activity]
   726 E C0024779:Map [Manufactured Object]
   726 E C1706473:Map [Conceptual Entity]
Processing 00000000.tx.238: Mamm. 

Phrase: "Mamm."
Processing 00000000.tx.239: Genome, 10, 410414.[ISI][Medline] 15 Shimizu, C., Akazawa, C., Nakanishi, S. and Kageyama, R. 

Phrase: "Genome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "10,"

Phrase: "410414."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 15 Shimizu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Akazawa,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nakanishi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kageyama,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.240: (1995) MATH-2, a mammalian helixloophelix factor structurally related to the product of Drosophila proneural gene atonal, is specifically expressed in the nervous system. 

Phrase: "(1995"

Phrase: ")"

Phrase: "MATH-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1422203:Math-2 [Gene or Genome]
   861   C0024934:Math [Occupation or Discipline]

Phrase: "a mammalian helixloophelix factor structurally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "related to the product of Drosophila proneural gene"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   767   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0013138:Drosophila [Eukaryote]
   744   C0017337:Gene [Gene or Genome]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1028876:Drosophila [Fungus]
   744   C1504613:Drosophila [Eukaryote]
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]
   711 E C0163712:Relate [Organic Chemical]

Phrase: "atonal,"

Phrase: "is"

Phrase: "specifically"

Phrase: "expressed in the nervous system."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0027763:Nervous System [Body System]
   806   C0422837:NERVOUS SYSTEM [Finding]
   806   C1269560:Nervous system [Body System]
   760   C0027769:Nervous [Sign or Symptom]
   760   C0449913:System [Functional Concept]
   760   C0599851:Nervous [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   751 E C0205494:Neurologic [Qualitative Concept]
   714 E C0027855:Neurology [Biomedical Occupation or Discipline]
Processing 00000000.tx.241: Eur. 

Phrase: "Eur."
Processing 00000000.tx.242: J. 

Phrase: "J."
Processing 00000000.tx.243: Biochem., 229, 239248.[Abstract] 16 Peyton, M., Stellrecht, C.M., Naya, F.J., Huang, H.P., Samora, P.J. and Tsai, M.J. 

Phrase: "Biochem.,"

Phrase: "229,"

Phrase: "239248."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 16 Peyton,"

Phrase: "M."

Phrase: ","

Phrase: "Stellrecht,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Naya,"

Phrase: "F.J.,"

Phrase: "Huang,"

Phrase: "H.P.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Samora,"

Phrase: "P.J."

Phrase: "and"

Phrase: "Tsai,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.244: (1996) BETA3, a novel helixloophelix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes. 

Phrase: "(1996"

Phrase: ")"

Phrase: "BETA3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420841:BETA3 [Gene or Genome]
  1000   C2698300:Beta3 [Gene or Genome]

Phrase: "a novel helixloophelix protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "act as a negative regulator of BETA2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0182953:REGULATOR [Medical Device]
   748   C0205160:Negative [Qualitative Concept]
   748   C1417683:BETA2 [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]
   748   C1823554:Beta2 [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   748   C3273872:BETA2 [Gene or Genome]

Phrase: "and"

Phrase: "MyoD-responsive genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.245: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.246: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.247: Biol., 16, 626633.[Abstract] 17 Akazawa, C., Ishibashi, M., Shimizu, C., Nakanishi, S. and Kageyama, R. 

Phrase: "Biol.,"

Phrase: "16,"

Phrase: "626633."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 17 Akazawa,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ishibashi,"

Phrase: "M."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nakanishi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kageyama,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.248: (1995) A mammalian helixloophelix factor structurally related to the product of Drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system. 

Phrase: "(1995"

Phrase: ")"

Phrase: "A mammalian helixloophelix factor structurally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "related to the product of Drosophila proneural gene"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   767   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0013138:Drosophila [Eukaryote]
   744   C0017337:Gene [Gene or Genome]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1028876:Drosophila [Fungus]
   744   C1504613:Drosophila [Eukaryote]
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]
   711 E C0163712:Relate [Organic Chemical]

Phrase: "atonal"

Phrase: "is"

Phrase: "a positive transcriptional regulator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040649:Transcriptional [Genetic Function]
   827   C0182953:REGULATOR [Medical Device]
   827   C1704734:Regulator [Medical Device]
   827   C1704735:Regulator [Conceptual Entity]

Phrase: "expressed in the developing nervous system."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   734 E C0205494:Neurologic [Qualitative Concept]
Processing 00000000.tx.249: J. 

Phrase: "J."
Processing 00000000.tx.250: Biol. 

Phrase: "Biol."
Processing 00000000.tx.251: Chem., 270, 87308738.[Abstract/Free FullText] 18 Pastorcic, M. and Das, H.K. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "270,"

Phrase: "87308738."

Phrase: "[Abstract/Free FullText"

Phrase: "] 18 Pastorcic,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "H.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.252: (1999) An upstream element containing an ETS binding site is crucial for transcription of the human presenilin-1 gene. 

Phrase: "(1999"

Phrase: ")"

Phrase: "An upstream element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an ETS binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "crucial for transcription of the human presenilin-1 gene."
Processing 00000000.tx.253: J. 

Phrase: "J."
Processing 00000000.tx.254: Biol. 

Phrase: "Biol."
Processing 00000000.tx.255: Chem., 274, 2429724307.[Abstract/Free FullText] 19 Zhang, W., Shields, J.M., Sogawa, K., Fujii-Kuriyama, Y. and Yang, V.W. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "2429724307."

Phrase: "[Abstract/Free FullText"

Phrase: "] 19 Zhang,"

Phrase: "W.,"

Phrase: "Shields,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0183251:shields [Medical Device]
   966 E C1705198:Shield [Medical Device]

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Sogawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fujii-Kuriyama,"

Phrase: "Y."

Phrase: "and"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "V.W."
Processing 00000000.tx.256: (1998) The gut-enriched Kruppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The gut-enriched Kruppel-like factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0529085:Gut-Enriched Krueppel-Like Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416660:GUT-ENRICHED KRUPPEL-LIKE FACTOR [Gene or Genome]
   897   C0072059:Gut Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0017189:Gut [Body System]
   804   C0359583:enriched [Food]
   804   C0699819:Gut [Body Part, Organ, or Organ Component]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the activity of the CYP1A1 promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in an Sp1-dependent fashion."
Processing 00000000.tx.257: J. 

Phrase: "J."
Processing 00000000.tx.258: Biol. 

Phrase: "Biol."
Processing 00000000.tx.259: Chem., 273, 1791717925.[Abstract/Free FullText] 20 Chaudhry, A.Z., Lyons, G.E. and Gronostajski, R.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "273,"

Phrase: "1791717925."

Phrase: "[Abstract/Free FullText"

Phrase: "] 20 Chaudhry,"

Phrase: "A.Z.,"

Phrase: "Lyons,"

Phrase: "G.E."

Phrase: "and"

Phrase: "Gronostajski,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.260: (1997) Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Expression patterns of the four nuclear factor I genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449774:Patterns [Spatial Concept]

Phrase: "during mouse embryogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "indicate"

Phrase: "a potential role in development."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.261: Dev. 

Phrase: "Dev."
Processing 00000000.tx.262: Dyn., 208, 313325.[ISI][Medline] 21 Kehoe, P., Wavrant-De Vrieze, F., Crook, R., Wu, W.S., Holmans, P., Fenton, I., Spurlock, G., Norton, N., Williams, H., Williams, N. et al. 

Phrase: "Dyn.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600130:dyn [Quantitative Concept]

Phrase: "208,"

Phrase: "313325."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 21 Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wavrant-De Vrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "W.S.,"

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fenton,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Spurlock,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Norton,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Williams,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Williams,"

Phrase: "N. et al."
Processing 00000000.tx.263: (1999) A full genome scan for late onset Alzheimers disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A full genome scan for late onset Alzheimers disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1517519:Genome Scan [Molecular Biology Research Technique]
   742   C0017428:Genome [Gene or Genome]
   742   C0034606:Scan [Diagnostic Procedure]
   742   C0441633:Scan [Diagnostic Procedure]
   742   C2338314:Genome [Conceptual Entity]
   742   C2826292:SCAN [Finding]
Processing 00000000.tx.264: Hum. 

Phrase: "Hum."
Processing 00000000.tx.265: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.266: Genet., 8, 237245.[Abstract/Free FullText] 22 Hauser, E.R., Boehnke, M., Guo, S.W. and Risch, N. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "237245."

Phrase: "[Abstract/Free FullText"

Phrase: "] 22 Hauser,"

Phrase: "E.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Boehnke,"

Phrase: "M."

Phrase: ","

Phrase: "Guo,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Risch,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.267: (1996) Affected-sib-pair interval mapping and exclusion for complex genetic traits: sampling considerations. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Affected-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "sib-pair interval mapping"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C1272706:Interval [Temporal Concept]
   812   C1283195:Mapping [Activity]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   779 E C0024779:Map [Manufactured Object]
   779 E C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "exclusion for complex genetic traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]

Phrase: ":"

Phrase: "sampling considerations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:considerations [Finding]
Processing 00000000.tx.268: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.269: Epidemiol., 13, 117137.[ISI][Medline] 23 Hardy, J. 

Phrase: "Epidemiol.,"

Phrase: "13,"

Phrase: "117137."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 23 Hardy,"

Phrase: "J."
Processing 00000000.tx.270: (1997) Amyloid, the presenilins and Alzheimers disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.271: Trends Neurosci., 20, 154159.[ISI][Medline] 24 Refolo, L., Eckman, C., Prada, C.M., Yager, D. and Younkin, S. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "20,"

Phrase: "154159."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 24 Refolo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Prada,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.272: (1998) Antisense reduction of presenilin 1 significantly increases A42 (43) secreted by human embryonic kidney cells. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Antisense reduction of presenilin 1 significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A42"

Phrase: "(43"

Phrase: ")"

Phrase: "secreted by human embryonic kidney cells."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   783   C0427861:Human cells [Laboratory or Test Result]
   783   C0553257:cells kidney [Cell]
   767   C1947950:Embryonic Cell [Embryonic Structure]
   753   C0007634:Cells [Cell]
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1327616:Secreted [Cell Function]
   753   C1514845:KIDNEY [Tissue]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.273: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.274: Aging, 19, S63. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "19,"

Phrase: "S63."
Processing 00000000.tx.275: 25 De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K. and Van Leuven, F. 

Phrase: "25 De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guhde,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Von Figura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.276: (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Deficiency of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1623416:deficiency [Qualitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the normal cleavage of amyloid precursor protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
Processing 00000000.tx.277: Nature, 391, 387390.[ISI][Medline] 26 Lambert, J.C., Pasquier, F., Cottel, D., Frigard, B., Amouyel, P. and Chartier-Harlin, M.C. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "391,"

Phrase: "387390."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 26 Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Pasquier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cottel,"

Phrase: "D."

Phrase: ","

Phrase: "Frigard,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Amouyel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Chartier-Harlin,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.278: (1998) A new polymorphism in the APOE promoter associated with risk of developing Alzheimers disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A new polymorphism in the APOE promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with risk of developing Alzheimers disease."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0002395:Alzheimers disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0243083:associated disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.279: Hum. 

Phrase: "Hum."
Processing 00000000.tx.280: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.281: Genet., 7, 533540.[Abstract/Free FullText] 27 Lambert, J.C., Berr, C., Pasquier, F., Delacourte, A., Frigard, B., Cottel, D., Perez-Tur, J., Mouroux, V., Mohr, M., Cecyre, D. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "533540."

Phrase: "[Abstract/Free FullText"

Phrase: "] 27 Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Berr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pasquier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Delacourte,"

Phrase: "A.,"

Phrase: "Frigard,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cottel,"

Phrase: "D."

Phrase: ","

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Mouroux,"

Phrase: "V.,"

Phrase: "Mohr,"

Phrase: "M."

Phrase: ","

Phrase: "Cecyre,"

Phrase: "D. et al."
Processing 00000000.tx.282: (1998) Pronounced impact of Th1/E47cs mutation compared with 491 AT mutation on neural APOE gene expression and risk of developing Alzheimers disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Pronounced impact of Th1/E47cs mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "compared with 491"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "AT mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on neural APOE gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017262:Gene Expression [Genetic Function]
   861   C1412481:APOE gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "risk of developing Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.283: Hum. 

Phrase: "Hum."
Processing 00000000.tx.284: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.285: Genet., 7, 15111516.[Abstract/Free FullText] 28 Bullido, M.J., Artiga, M.J., Recuero, M., Sastre, I., Garcia, M.A., Aldudo, J., Lendon, C., Han, S.W., Morris, J.C., Frank, A. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "15111516."

Phrase: "[Abstract/Free FullText"

Phrase: "] 28 Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Recuero,"

Phrase: "M."

Phrase: ","

Phrase: "Sastre,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Aldudo,"

Phrase: "J.,"

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Morris,"

Phrase: "J.C., Frank,"

Phrase: "A. et al."
Processing 00000000.tx.286: (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimers dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A polymorphism in the regulatory region of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for Alzheimers dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:alzheimers dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.287: Nature Genet., 18, 6971.[ISI][Medline] 29 Wavrant-De Vrieze, F., Crook, R., Holmans, P., Kehoe, P., Owen, M.J., Williams, J., Roehl, K., Laliiri, D.K., Shears, S., Booth, J. et al. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "6971."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 29 Wavrant-De Vrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Owen,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "Roehl,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Laliiri,"

Phrase: "D."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shears,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175735:shears [Medical Device]
   966 E C0205013:shear [Therapeutic or Preventive Procedure]

Phrase: "S."

Phrase: ","

Phrase: "Booth,"

Phrase: "J. et al."
Processing 00000000.tx.288: (1999) Genetic variability at the amyloid- precursor protein locus may contribute to the risk of late-onset Alzheimers disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genetic variability at the amyloid- precursor protein locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2827666:Variability [Conceptual Entity]

Phrase: "may"

Phrase: "contribute to the risk of late-onset Alzheimers disease."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   781   C0814122:late disease onset [Finding]
   764   C0002395:Alzheimers disease [Disease or Syndrome]
   762   C0277793:disease onset [Temporal Concept]
   762   C1281905:disease risk [Finding]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205087:Late [Temporal Concept]
   742   C0332162:Onset [Qualitative Concept]
   742   C1880177:Contribute [Activity]
Processing 00000000.tx.289: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.290: Lett., 269, 6770.[ISI][Medline] 30 van Duijn, C.M., Hendriks, L., Farrer, L.A., Backhovens, H., Cruts, M., Wehnert, A., Hofman, A. and Van Broeckhoven, C. 

Phrase: "Lett.,"

Phrase: "269,"

Phrase: "6770."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 30 van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Hendriks,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "L.A.,"

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.291: (1994) A population-based study of familial Alzheimer disease: linkage to chromosomes 14, 19, and 21. 

Phrase: "(1994"

Phrase: ")"

Phrase: "A population-based study of familial Alzheimer disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1709599:Population Based Study [Research Activity]
   767   C0199236:Familial Study [Diagnostic Procedure]
   767   C0681876:Population Study [Research Activity]
   767   C2348561:Study Population [Population Group]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "linkage to chromosomes 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "19,"

Phrase: "and"

Phrase: "21."
Processing 00000000.tx.292: Am. 

Phrase: "Am."
Processing 00000000.tx.293: J. 

Phrase: "J."
Processing 00000000.tx.294: Hum. 

Phrase: "Hum."
Processing 00000000.tx.295: Genet., 55, 714727.[ISI][Medline] 31 Hendriks, L., van Duijn, C.M., Cras, P., Cruts, M., Van Hul, W., Van Harskamp, F., Warren, A., McInnis, M.G., Antonarakis, S.E. and Martin, J.J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "714727."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 31 Hendriks,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Cras,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Van Hul,"

Phrase: "W.,"

Phrase: "Van Harskamp,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Warren,"

Phrase: "A.,"

Phrase: "McInnis,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Antonarakis,"

Phrase: "S."

Phrase: "E."

Phrase: "and"

Phrase: "Martin,"

Phrase: "J.J."
Processing 00000000.tx.296: (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the -amyloid precursor protein gene. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Presenile dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011265:Pre-senile dementia [Mental or Behavioral Dysfunction]
           dementia
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "cerebral haemorrhage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2937358:Cerebral Hemorrhage [Pathologic Function]
   861   C0019080:Haemorrhage [Pathologic Function]

Phrase: "linked to a mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "at codon 692"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "of the -amyloid precursor protein gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.297: Nature Genet., 1, 218221.[ISI][Medline] 32 Hofman, A., Grobbee, D.E., de Jong, P.T. and van den Ouweland, F.A. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "218221."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 32 Hofman,"

Phrase: "A.,"

Phrase: "Grobbee,"

Phrase: "D."

Phrase: "E.,"

Phrase: "de Jong,"

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "van den Ouweland,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.298: (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Determinants of disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521761:Determinant [Functional Concept]

Phrase: "and"

Phrase: "disability in the elderly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231170:Disability [Finding]

Phrase: ":"

Phrase: "the Rotterdam Elderly Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.299: Eur. 

Phrase: "Eur."
Processing 00000000.tx.300: J. 

Phrase: "J."
Processing 00000000.tx.301: Epidemiol., 7, 403422.[ISI][Medline] 33 Strathmann, M., Hamilton, B.A., Mayeda, C.A., Simon, M.I., Meyerowitz, E.M. and Palazzolo, M.J. 

Phrase: "Epidemiol.,"

Phrase: "7,"

Phrase: "403422."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 33 Strathmann,"

Phrase: "M."

Phrase: ","

Phrase: "Hamilton,"

Phrase: "B.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Mayeda,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Simon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:Simon [Intellectual Product]

Phrase: "M.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Meyerowitz,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Palazzolo,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.302: (1991) Transposon-facilitated DNA sequencing. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Transposon-facilitated DNA sequencing."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0162326:DNA sequencing [Nucleotide Sequence]
   861   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   812   C1553778:Sequencing [Intellectual Product]
   812   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.303: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.304: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.305: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.306: USA, 88, 12471250.[Abstract] 34 Terwilliger, J.D. and Ott, J. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "88,"

Phrase: "12471250."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 34 Terwilliger,"

Phrase: "J.D."

Phrase: "and"

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.307: (1994) Handbook of Human Genetic Linkage. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Handbook of Human Genetic Linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596654:handbook [Intellectual Product]
Processing 00000000.tx.308: John Hopkins University Press, New York, NY. 

Phrase: "John Hopkins University Press,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.309: 35 Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. 

Phrase: "35 Quandt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Frech,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Karas,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wingender,"

Phrase: "E."

Phrase: "and"

Phrase: "Werner,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.310: (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. 

Phrase: "(1995"

Phrase: ")"

Phrase: "MatInd"

Phrase: "and"

Phrase: "MatInspector"

Phrase: ":"

Phrase: "new fast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015663:Fast [Finding]
   861   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "versatile tools for detection of consensus matches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0336791:Tool [Manufactured Object]
   714   C2827396:Tool [Manufactured Object]

Phrase: "in nucleotide sequence data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0004793:Nucleotide Sequence [Nucleotide Sequence]
Processing 00000000.tx.311: Nucleic Acids Res., 23, 48784884.[Abstract]

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "48784884."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

